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Abstract
Background: The aminoglycoside antibiotic gentamicin is an ototoxic drug and has been used experimentally to
investigate cochlear damage induced by noise.
We have investigated the changes in the protein profile associated with caveolae in gentamicin treated and untreated
spiral ligament (SL) pericytes, specialized cells in the blood labyrinth barrier of the inner ear microvasculature. Pericytes
from various microvascular beds express caveolae, protein and cholesterol rich microdomains, which can
undergo endocytosis and transcytosis to transport small molecules in and out the cells. A different protein profile in
transport-specialized caveolae may induce pathological changes affecting the integrity of the blood labyrinth barrier
and ultimately contributing to hearing loss.
Method: Caveolae isolation from treated and untreated cells is achieved through ultracentrifugation of the lysates in
discontinuous gradients. Mass spectrometry (LC-MS/MS) analysis identifies the proteins in the two groups.
Proteins segregating with caveolae isolated from untreated SL pericytes are then compared to caveolae
isolated from SL pericytes treated with the gentamicin for 24 h. Data are analyzed using bioinformatic tools.
Results: The caveolae proteome in gentamicin treated cells shows that 40% of total proteins are uniquely associated
with caveolae during the treatment, and 15% of the proteins normally associated with caveolae in untreated cell are
suppressed. Bioinformatic analysis of the data shows a decreased expression of proteins involved in genetic information
processing, and an increase in proteins involved in metabolism, vesicular transport and signal transduction in gentamicin
treated cells. Several Rab GTPases proteins, ubiquitous transporters, uniquely segregate with caveolae and are significantly
enriched in gentamicin treated cells.
Conclusion: We report that gentamicin exposure modifies protein profile of caveolae from SL pericytes. We identified a
pool of proteins which are uniquely segregating with caveolae during the treatment, mainly participating in metabolic
and biosynthetic pathways, in transport pathways and in genetic information processing. Finally, we show for the first
time proteins associated with caveolae SL pericytes linked to nonsyndromic hearing loss.
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Background
The aminoglycoside antibiotic gentamicin (GTM) used
in the treatment of bacterial infections has important
ototoxic side effects. It can induce vestibulotoxicity char-
acterized by vertigo and dizziness and cochleotoxicity,
manifesting as tinnitus and permanent sensorineural
hearing impairment and loss [1]. The incidence of hear-
ing loss is up to 25% among patients treated with the
antibiotic [2]. GTM is used to treat infections in a wide
demographic span from adults, to children, to infants
including preterm infants. In children and neonates the
incidence of cochlear and vestibular toxicity is less than
in adults [3]. The risk of ototoxicity increases when
GTM is administered concurrently with other ototoxic
drugs such as chemotherapeutic agents, loop diuretics
or glycopeptides antibiotics [4, 5] and/or concurrently
with noise exposure [3] old age [1] and in patients with
mitochondrial DNA mutation 1555A > G. [1, 5, 6].
Despite its toxic side effects GTM is one of the antibiotics
of choice worldwide due to the relatively low cost and its
wide spectrum of action comprising many strains of Gram-
positive and Gram-negative pathogens [4]. GTM can be
administered intravenously or intramuscularly. Ototoxicity
correlates with plasma concentration and duration of the
therapy [7]. The symptoms can arise during the drug
administration or after the end of the therapy; hence GTM
is usually delivered in an inpatient setting when the drug
blood level can be routinely monitored. GTM penetrates all
cell types of the cochlea, and continues to accumulate in
the inner ear even after the termination of its administra-
tion [8–11]. Following systemic administration, GTM and
the aminoglycosides are presumably trafficked through the
endothelial cells in the microvasculature of the cochlear
lateral wall into the perilymphatic fluids [3]. More recent
evidences strongly suggest that aminoglycosides may be
predominantly trafficked through the blood labyrinth
barrier (BLB) into the SV and into the endolymph before
entering the cochlear hair cells. Within the inner ear peri-
lymph, plasma concentrations of GTM increase in a time
and dose dependent manner. The recognized cellular basis
for aminoglycoside-induced hearing loss is the death of
mechanosensory cochlear hair cells. Chronic GTM treat-
ment leads to cell loss and reduction of thickness of the
stria vascularis (SV) [12]. In guinea pigs a single dose of
GTM, systemically or locally administered, persists in SL
fibrocytes, suggesting that hair cell vulnerability may be
influenced by the state of spiral ligament cells [11].
Although the molecular mechanisms are poorly under-
stood, aminoglycoside antibiotics generate free radicals
within the inner ear, damaging sensory cells and neurons
and inducing apoptosis [13]. Two major vascular beds form
the lateral wall microvasculature of the inner ear, the SV
and the SL, deliver about 80% of the blood supply to the
cochlea. The SL microvasculature surrounding the SV
controls the blood flow directed to the stria vascular bed
[14, 15] through contractile proteins of the SL pericytes
(Fig. 1). Pericytes also control other important functions in
the microvasculature physiology such as: maintenance of
the blood-labyrinth barrier (BLB), signaling pathways to
endothelial cells, and modulation of the microvessel wall
permeability [8]. Transport of macromolecules across the
BLB via transcytotic and endocytotic mechanisms consti-
tute another likely function of the pericytes in the inner ear.
Recently, it has been shown that, in the blood brain barrier
(BBB), pericyte signaling to endothelial cells control the
vesicular transcytosis through the up- or down-regulation
of Mfsd2a protein on the cell surface of endothelial cell
membrane [16]. Caveolae are cholesterol rich membrane
microdomains found on many cell types and particularly
abundant on endothelial cells and adipocytes. Pericytes
from various microvascular beds have also been described
expressing caveolae, transporting small molecules into the
cells and unloading cargoes into the extracellular space
[17]. Caveolae are described mainly on the cell surface and
in the cytoplasm; they are constituted of cholesterol, phos-
pholipids, sphingolipids and proteins. Caveolae contain
constitutive proteins such as caveolin 1 (cav1), caveolin 2
(cav2) and caveolin 3 (cav3). Cav1 is a structural protein es-
sential for caveolae formation observed also in the nucleus
[18] in the cytoplasm, and in organelles such as mitochon-
dria [19]. Cav1 and cav2 are abundant in non-muscle cells,
Cav3 is found in skeletal muscles and in some smooth-
muscle cells. Ablation of cav1 or cav3 but not cav2 causes
disassembly and loss of caveolae [20].
Several members of the Rab GTPase family have been
shown to coordinate and participate in caveolae endocytosis
[21, 22]. Proteins of the Rab GTPase family are cellular
regulators of vesicular transport and membrane trafficking.
In humans, the recognized members of the Rab family
account for more than 60 proteins localized in various cel-
lular membranes. Rabs alternate between the active GTP
(guanosine triphosphate)-bound and the inactive GDP
(guanosine diphosphate)-bound conformation, and partici-
pate in specifying transport pathways in the intracellular
membrane trafficking system of all eukaryotes. These path-
ways comprise endocytosis, exocytosis, phagocytosis, re-
cruitment of tethering factors, control of anterograde and
retrograde trafficking between membranes and organelles,
and the coordination of cargo delivery and membrane
recycling [23, 24]. Finally, proteins relevant for hearing loss
have been shown to segregate with caveolae. In particular,
in their analysis of proteins associated with cholesterol-rich
membrane microdomains in the inner ear cells, Thomas P.
and colleagues [25] identified a number of proteins involved
in human nonsyndromic deafness. Nonsyndromic hearing
loss is defined as loss occurring without other clinically de-
tectable symptoms. It is characterized by mild-to-profound
sensorineural hearing impairment, and it is caused by
Ghelfi et al. Proteome Science  (2018) 16:7 Page 2 of 26
genetic mutations in proteins expressed in the middle ear,
the inner ear or in both. So far, 93 protein-encoding genes
linked to nonsyndromic hearing loss have been identified
but not all of them are fully characterized [26]. Among the
characterized nonsyndromic pathologies, one has been
shown to result in excessive endocytosis and accumulation
of caveolae. Prelingual nonsyndromic autosomic recessive
deafness 1 (DFNB1) is caused by mutations in the Gap
junction protein beta 2 (GJB2) gene encoding for the coch-
lear gap junction protein connexin 26 (CX26). One of the
mutations induces degradation of the gap junction com-
plexes through abnormal accumulation of cav1 and cav2
positive vesicles and increase of endocytosis leading to
membrane retrieval [27].
In this study, it is shown that the administration of
GTM to the SL pericytes induces changes in caveolae
proteome profile. In particular, proteome changes occur
in the association of Rab GTPase proteins, which are
master controllers of the intracellular vesicular trans-
port. Furthermore, we showed for the first time that SL
pericytes express cav1 and cav2 but not cav3, independ-
ently of GTM exposure. Finally, we identified proteins
known to be associated with nonsyndromic hearing loss
in the caveolae of SL pericytes.
Aims
The aim of this study is to investigate whether changes
occur in the proteins profile associated with caveolae in
Fig. 1 Cochlea and lateral wall schematic. The cochlea is part of the inner ear; it is the organ of hearing. It harbors at its center the membranous labyrinth
where the sensory cells reside. The cochlea is a spiral shell-like structure; it is encased in the temporal bone and contains three canals spiraling in two and
one half turns. Two of the canals, scala tympani and scala vestibuli are filled with perilymph a fluid similar to the cerebrospinal fluid and plasma ultrafiltrate
[116]. A third canal named scala media is separated from scala tympani and scala vestibuli by two membranes rich in tight junctions, the Reissner’s membrane
and the Basilar membrane respectively. Scala media contains the endolymph a uniquely potassium-rich, positively polarized fluid, originating from the active
filtration of the SV. The SV and the SL form the lateral wall of the inner ear, their microvasculature constitutes the blood labyrinth barrier (BLB) and functions
with the tissue highly specialized cells to maintain the ionic composition of the endolymph and perilymph. Three different cell types are recognized in the
SV; marginal, intermediate and basal cells. The marginal cells (MC) secrete K+, they constitute a homogeneous layer of epithelial cells lining the scala media
fluid space, connected by tight junctions, adherens junctions and desmosomes. Marginal cells are rich in microvilli on the luminal side and lack a basement
membrane on the opposite side, directly associating them with the vasculature beneath them [117]. Intermediate cells (IC) rich in melanin granules intertwine
with the marginal cells without reaching the luminal side. Basal cells (BC) are lateral to the intermediate cell layer adjacent to the SL. The SL comprises five
types of fibrocytes (I-V). The fibrocytes participate in pumping K+ out of the perilymph (Type II, IV, and V) and transport it to generate the
endochoclear potential in the endolynph (Type I) [117]. In the figure: stria vascularis (SV). Spiral ligament (SL), marginal cells (MC), intermediate
cells (IC), basal cells (BC), inner hair cells (IHC), outer hair cells (OHC), fibrocytes type I-V (Type I-V), circles are schematic representation
of microvessels
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GTM treated SL pericytes. A different protein profile in
transport-specialized caveolae may indicate pathological
changes potentially affecting the integrity of the BLB
and ultimately contributing to hearing loss.
Methods
Cell isolation and culturing
SL pericytes were isolated from cochlea obtained from
ImmortoMouse® (Charles River Laboratories, USA) carry-
ing a conditional thermosensitive SV40 large T antigen
functional at the permissive temperature of 33 °C but
non-functional at the nonpermissive temperature of
39 °C [28, 29]. All experiments were conducted at the
temperature of 39 °C.
Four-week-old mice were euthanized with CO2 and de-
capitated. Rapidly, the brain tissue was removed and both
cochleae were extracted by fracturing the petrous portion
of the temporal bone. Cochleae were then bathed in the ice
cold transfer medium, containing Ca++ and Mg++ (HBSS
Cellgro 21–023-CV, Mediatech, Inc. USA) and 20% Fetal
Bovine Serum (FBS) (GIBCO 10091–130, Thermo Fisher
Scientific, USA). The lateral wall tissue consisting of SL and
SV was separated from the cochlear structure, and the two
tissues further separated by using tweezers (Type 5 mini,
super thin tips, DuMont, Electron Microscopy Science,
USA) and a Zeiss Stereo Discovery V12 dissection micro-
scope (Carl Zeiss Microscopy LLC, USA). Tissues were
digested in a mixture of Dispase grade II protease (Roche
Diagnostic, USA), collagenase type I and collagenase type
IV (GIBCO, Thermo Fisher Scientific, USA) for 15 min at
37 °C in 5% CO2. Tissue digestion was stopped with 1 ml
of neutralizing buffer consisting of DPBS without Ca++ and
Mg++ supplemented with 10% FBS (GIBCO, Thermo Fisher
Scientific, USA). The suspension was pipetted gently up
and down in order to further separate the cells, then passed
through a 70 μm cell strainer (Falcon™, Fisher Scientific,
USA) and centrifuged (Beckman centrifuge GS 6R, USA) in
ice cold neutralizing buffer for 10 min at 900 rpm. Cells
were incubated in MV media without vascular endothelial
growth factor (VEGF) to support pericyte growth (MV
Media + kit, PromoCell, Heidelberg, Germany), in culture
wells coated with gelatin (Cell Biologics Inc. Chicago, USA)
and allowed to proliferate until 90% confluence was reached.
CD31 and CD146 markers for endothelial cells and pericytes
(anti-mouse CD31 antibody PE Cy7 Biolegend 1/100; and
anti-mouse CD146 PE Biolegend 1/100), were used to sort
the positive cells with a flow sorter FACSAria, (Harvard
Medical School Flow Cytometry Core Facility, Boston, USA)
(data not shown). Sorted cells were plated in vessels pre-
coated with gelatin-based solution in MV media. Cells were
confirmed as pericytes by flow cytometric analysis using the
Accuri C6 Cytometer (BD Bioscience, USA). Cells tested
negative for the endothelial cell marker anti-von Willebrand
factor (vWF), sheep polyclonal Abcam, USA, with secondary
antibody Alexa Fluor 488 donkey anti-sheep, Life technol-
ogy, USA), and positive for the pericytes markers chondro-
itin sulfate proteoglycan 4 (NG2) (anti-NG2 antibody mouse
monoclonal, Abcam, USA; secondary Alexa Fluor 488 goat
anti-mouse, Life technology, USA) and Desmin (anti-desmin
antibody rabbit monoclonal Abcam, USA; secondary Alexa
Fluor 488 goat anti-rabbit, Life Technology, USA). Pericytes
were further characterized as SL pericytes with the alpha-
Smooth-Muscle-Actin (α-SMA), a protein absent in stria
vascularis pericytes and a marker of SL pericytes (rabbit
monoclonal anti-α-SMA, Abcam, USA; secondary was
Alexa Fluor 488 goat anti-rabbit, Life Technologies,
USA). SL pericyte cultures were expanded in gelatin
coated T-75 flasks until a 80–90% confluence was
reached, in a 5% CO2 environment at 39 °C and used
according to the experimental design. When GTM
(Gentamicin solution, AMRESCO, Solon, Ohio) was
dissolved in MV media, sodium hydroxide (5 N solu-
tion, Fisher Scientific, USA) was added to the solution
to adjust media pH.
Caveolae isolation and protein analysis
Sample and gradient preparation: SL pericytes were de-
tached from 150 cm2 flasks with Accutase cell detachment
solution (BD Bioscience, USA) and washed twice in cold
PBS. Caveolae/Raft isolation kit (Sigma–Aldrich, USA) was
used according to the manufacturer’s instructions. All the
procedures for the isolation of caveolae from SL pericytes:
cell preparation, manipulation, as well as gradient prepar-
ation were conducted in a 4 °C cold room. The lysis buffer
containing 1% Triton X-100 and protease inhibitor cocktail
as well as the OptiPrep™ density gradient solutions used for
the caveolae separation were prepared immediately before
use and kept on ice. Tubes, pipets, pipet-tips, centrifuge
and ultracentrifuge rotors used in the experiment were pre-
chilled at 4 °C.
Briefly, cells were suspended in 100 μl of lysis buffer and
kept on ice for at least 30 min. Aliquots of cell lysate were
combined in a solution of 35% OptiPrep Density Gradient
Medium and transferred to the bottom of a bell-top polyal-
lomer ultracentrifuge OptiSeal tube (Beckman Coulter Inc.
Brea, CA, USA). Four volumes of dilutions of OptiPrep™ in
lysis buffer at the decreasing concentration of 30, 25 and
20% were then carefully layered from the bottom up of the
OptiSeal tube containing the cell lysate, for a final volume
of 4 ml. The Optiseal tubes were then centrifuged at
200,000 x g for 4 h at 4 °C with an Optima TLX ultracentri-
fuge equipped with a TLA 110 rotor (Beckman Coulter Inc.
Brea, CA, USA). Once the ultracentrifugation was com-
pleted, the tubes were carefully extracted from the rotor
and kept on ice. A pre-chilled manual pipette was used to
collect eight or nine aliquots of approximately 0.5 ml each
from the top down of each ultracentrifuge tube in a 4 °C
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environment. Aliquots were collected in ice cold microcen-
trifuge tubes and kept on ice.
Dot-blot detection of caveolin-1 enriched aliquots
In order to identify the caveolae-rich aliquot, 3 μl from each
gradient aliquot obtained from the ultracentrifugation was
placed on a Polyvinylidene fluoride (PVDF) membrane
(Immun-Blot® PVDF membrane, BIO-RAD Laboratories,
USA) previously activated in 100% methanol (J.T. Baker,
USA) and kept moist with filter paper rectangles (Mini
Trans-Blot, BIO-RAD Laboratories Inc. USA) soaked in
ultrapure MQ water. The aliquots’ drops were adsorbed on
the membrane for a few minutes, and then incubated with
5% nonfat milk in PBS-T (Phosphate Buffered Saline with
1%Tween 20) for 1 h at room temperature and further
incubated with anti-caveolin-1 antibody (Sigma-Aldrich,
USA) overnight at 4 °C in 5% nonfat milk. The membrane
was then washed with PBS-T and incubated for 1 h at room
temperature with diluted secondary antibody (anti-rabbit
IgG peroxidase conjugated, Life Technology, USA).
Membrane chemiluminescence was developed with
Clarity ECL substrate (Clarity Western ECL Substrate,
BIORAD laboratories, USA) and visualized with Chemidoc
MP Imaging System and software (BIORAD Laboratories,
USA) [see Additional file 1]. The aliquots with the strongest
signal for cav-1 were selected for protein separation and
mass spectrometry analysis.
Separation of proteins on SDS PAGE gel for mass
spectrometry analysis
Caveolae were isolated and prepared for the mass
spectrometry analysis in three independent experi-
ments. A volume of 15 μl from the selected gradient
aliquot was mixed with an equal volume of Laemmli
buffer (BIO-RAD Laboratories, USA) and then loaded
onto SDS precast gel TGX 4–15% (BIO-RAD Labora-
tories). Proteins were separated on the gel using a
Mini-protean TGX system (BIO-RAD Laboratories,
USA), bathed in running buffer solution (tris/glycine/
SDS 1X buffer BIO-RAD Laboratories, USA). Gels
were then incubated overnight in Coomassie blue for
protein staining and fixation and washed in ultrapure
water allowing several changes. The gel lanes were ex-
cised and separated into three fragments: roughly
above 75 kDa, below 25 kDa and between 25 and
75 kDa. The fragments were then submitted to mass
spectrometer. For the purpose of the analysis, the
three bioinformatic files representing the fragments
were subsequently reunited for the data analysis.
When a protein was detected in more than one frag-
ment, the peptide with the maximum counts was
retained.
Protein sequence analysis by LC-MS/MS
Excised gel fragments were cut into approximately
1 mm3 pieces and processed and analyzed by the Taplin
Mass Spectrometry Facility (Harvard Medical School,
Boston, MA). Gel pieces were subjected to a modified
in-gel trypsin digestion procedure [30]. Gel pieces were
then washed and dehydrated with acetonitrile for 10 min
followed by removal of acetonitrile. Pieces were then
completely dried in a Speed-Vac. Rehydration of the gel
pieces was done with 50 mM ammonium bicarbonate
solution containing 12.5 ng/μl modified sequencing-
grade trypsin (Promega, Madison, WI) at 4 °C. After
45 min, the excess trypsin solution was removed and re-
placed with 50 mM ammonium bicarbonate solution to
just cover the gel pieces. Samples were then placed in a
37 °C room overnight. Peptides were later extracted by
removing the ammonium bicarbonate solution, followed
by one wash with a solution containing 50% acetonitrile
and 1% formic acid. The extracts were then dried via
vacuum centrifugation (~ 1 h). The samples were then
stored at 4 °C until analysis. On the day of analysis the
samples were reconstituted in 5–10 μl of HPLC solvent
A (2.5% acetonitrile, 0.1% formic acid). A nanoscale
reverse-phase HPLC capillary column was created by
packing 2.6 μm C18 spherical silica beads into a fused
silica capillary (100 μm inner diameter x ~ 25 cm length)
with a flame-drawn tip [31]. After equilibrating the col-
umn each sample was loaded via a Famos autosampler
(LC Packings, San Francisco CA) onto the column. A
gradient was formed and peptides were eluted with in-
creasing concentrations of solvent B (97.5% acetonitrile,
0.1% formic acid). As peptides eluted, they were sub-
jected to electrospray ionization and then entered an
LTQ Orbitrap Velos Pro ion-trap mass spectrometer
(Thermo Fisher Scientific, San Jose, CA). The range of
masses (m/z mass over charge) allowed in the search
used was from 600 to 8000; charge z of the precursor
ion 2, 3 and 4; fragment mass tolerance 1 Da; cleavage
rule used: up to two missed cleavages. Modifications: dif-
ferential: methionine oxidation; static: cysteine alkylation
(iodoacetamide). Peptides were detected, isolated, and
fragmented to produce a tandem mass spectrum of specific
fragment ions for each peptide. Peptide sequences (and
hence protein identity) were determined by matching
protein databases with the acquired fragmentation pattern
by the software program, Sequest-v28 (Thermo Fisher, San
Jose, CA) [32]. All databases (Uniprot) include a reversed
version of all the sequences and the data was filtered to
between a one and 2 % peptide false discovery rate.
Only proteins detected in at least two of the three mass
spectrometry runs were considered for further bioinformatic
analysis. The latter was performed with R version 3.3.1 (R
Core Team) and visualization done with VennDiagram R
package [33] (https://www.r-project.org).
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Gene ontology enrichment analysis from identified
proteins
The web-server interactive software tool Gene Ontology
enRIchment anaLysis and visuaLizAtion tool or GOrilla
(http://cbl-gorilla.cs.technion.ac.il/) was selected for the
gene enrichment analysis. The program enables GO en-
richment analysis, identification and visualization of GO
terms in unranked lists of genes for the three GO cat-
egories biological processes, cellular components, and
molecular functions [34, 35]. The method identifies, in-
dependently for each GO term in the Mus musculus
ontology, the threshold at which the most significant en-
richment is obtained. Results are organized for a p-value
threshold ranging from p < 10− 3 to p > 10− 9. The false
discovery rate (FDR) q-value is associated with each
term’s p-value and it is the corrected p-value for mul-
tiple testing, using the Benjamini and Hochberg method.
The outputs are visualized in tables ranking the GO
terms according to the p-value and corresponding FDR
q-value, from the highest significant term down.
Proteomaps functions analysis
The metabolic functions of the uniquely expressed proteins
in the control and GTM data sets were visualized with the
web-based interactive software Proteomaps www.proteo-
maps.net. The software visualizes the composition of pro-
teomes with a focus on protein functions and abundance.
Proteins are assigned to functions via modified KEGG
(Kyoto Encyclopedia of Genes and Genomes) Orthology
IDs, and are shown in Proteomaps as polygon-shaped tiles,
with the area representing protein abundance. Proteomaps
runs a modified algorithm for the construction of Voronoi
treemaps to present polygons with variable sizes. The
algorithm was implemented in the Paver software (DECO-
DON, Greifswald, Germany) [36]. The mass spectrometry
detection did not estimate the abundance of the protein
obtained, therefore we assigned 1 as an arbitrary quantity
for the analysis of the proteins loaded onto Proteomaps
software, resulting in a map where areas represent the
number of proteins in an assigned function.
Nonsyndromic hearing loss protein segregating with
caveolae
Protein encoding genes from the three mass spectrom-
eter repeats were searched using the nonsyndromic
Gene Homepage database [26] (http://hereditaryhearin-
gloss.org). The site lists data and links for all known
gene localizations and identifications for monogenic
nonsyndromic hearing impairment.
Western blot analysis
SL pericyte cells were incubated for 24 h with GTM at
concentrations of 0, 1, 5 and 10 mg/ml. Cell lysates were
prepared with 1X lysis buffer (RIPA buffer, Cell Signaling
Technology). A protease and phosphatase inhibitor solution
(Protease/Phosphatase inhibitor cocktail, Cell Signaling
Technology, USA) was then added to the mixture. Proteins
were separated in a 4–15% SDS-PAGE (Mini-protean TGX
BIO-RAD Laboratories, USA) gel electrophoresis and
transferred using a Trans-Blot Turbo Transfer system
(BIO-RAD Laboratories, USA) using Trans Blot Turbo
transfer pack 0.2 μm PVDF membranes (BIO-RAD Labora-
tories, USA). Membranes were blocked in 5% fat-free milk
diluted in Tris-buffered saline with Tween (TBST; 0.1%
Tween-20, 150 mM NaCl, 50 mM Tris, pH 7.5) for 1 h.
The membranes were then incubated with purified mono-
clonal rabbit anti-caveolin 1 (Cell Signaling Technology,
USA 1/1000), anti-caveolin 2 rabbit polyclonal and anti-
caveolin 3 Rabbit polyclonal antibodies (Abcam, Boston,
MA). Anti-Rab antibodies used were: anti-Rab3a (Cell Sig-
naling Technology, USA, 1:1000), anti-Rab3b polyclonal
(Novus Biologicals, USA, 1:500), Rab family antibody sam-
pler kit (Cell Signaling Technology, USA, anti-Rab4; anti-
Rab5; anti-Rab7; anti-Rab9a; anti-Rab11; 1:1000), anti-
Rab6a polyclonal (GeneTex, USA, 1:100); anti-Rab6b poly-
clonal (Proteintech, Fisher Scientific, USA; 1:500), anti-
Rab8a monoclonal (Abcam, USA, 1:500), anti-Rab13 poly-
clonal (Abcam, USA, 1:500), anti-Rab22a monoclonal
(Abcam, USA, 1:1000), anti-Rab23 polyclonal (Abcam,
USA, 1:500), anti-Rab3gap2, polyclonal (GeneTex,
USA, 1:500). Monoclonal mouse anti-rabbit β-Actin
HRP conjugated antibody (1:1000, Cell Signaling Technol-
ogy, Danvers, MA, USA) was simultaneously incubated
with the primary antibody. The membranes were main-
tained at 4 °C, with gentle shaking overnight then incu-
bated with the secondary antibody (polyclonal goat anti-
rabbit immunoglobulins/HRP 1:2000, Dako) for 1 h at
room temperature. Bands were visualized using a Chemi-
doc MP Imaging system and software (BIO-RAD Labora-
tories, USA). The Rab proteins’ signal in each immunoblot
was normalized to the corresponding signal for β-actin
and the concentration of the Rab proteins was expressed
as the relative quantity to the control.
Annexin-V APC apoptotic assay
Cellular apoptosis was determined with an Annexin V
assay (Annexin V Apoptosis Detection Kit, Affymetrix,
eBioscience). SL pericytes were incubated for 24 h with
GTM at concentrations of 0, 1, 5, and 10 mg/ml. The
Annexin V assay was performed according to the manu-
facturer’s instructions. Cell fluorescence was measured
with Accuri C6 (BD Biosciences, San Jose, CA) flow cyt-
ometer using FITC detector filters at 530 nm for annexin
V and 600 nm for PI (Propidium Iodide). Data were ana-
lyzed using FlowJo software (FlowJo, LLC, Ashland, OR).
Data resulted from four independent experiments for
controls and three independent experiments for GTM-
treated cells. Statistical computation was performed with a
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one-way ANOVA, followed by a Dunnett’s test (9 degrees
of freedom) when data showed significance. Differences
were considered significant for p values less than 0.05.
Statistical tests were performed with R version 3.3.1 (R
core team).
Results
Characterization of SL pericytes
To exclude the presence of endothelial cells in the culture
we used the endothelial cell marker vWF. VWF is a large
glycoprotein expressed constitutively in endothelial cells and
megakaryocytes. The flow cytometry analysis showed that
nearly all cells (97.39%) did not express a signal for the vWF
marker (Fig. 2a). Next, we used a panel of pericyte markers
to precisely identify the cell type. The expression level of
pericyte markers can be up- or down-regulated depending
on various factors such as cell physiological status, patho-
logical status and culture conditions [37]. The validated peri-
cyte marker Desmin and NG2 were selected for the flow
cytometry analysis and cell characterization. Data showed
that 68.38% of the cells were positive for the antibodies
against Desmin and 48.17% of the cell population was
positive for the anti-NG2 antibody (Fig. 2b, c). We further
proceeded to the identification of SL pericytes using the vali-
dated pericyte marker α-SMA. The stria vascularis pericytes,
unlike other pericytes, do not express α-SMA [38] which is
considered a marker for SL pericytes. Data from the flow
cytometer analysis showed that 84.12% (Fig. 2d) of the cells
were positive for α-SMA, identifying the population as peri-
cytes of the spiral ligament microvasculature.
Cav1 and cav2 expression in SL pericytes was not
affected by gentamicin
To understand if GTM challenge to the cells would de-
plete SL pericytes caveolins, cultures were incubated for
24 h with several concentrations of GTM and changes
in the expression of caveolae proteins cav1 and cav2
were assayed with western blotting analysis. Cav1 is the
constitutive protein of caveolae; its expression is essen-
tial and required for the formation of morphologically
identifiable caveolae. Cav2 is usually coexpressed with
cav1, most abundantly in endothelial cells, fibrocytes,
and adipocytes, although its expression is regulated in-
dependently of cav1 and it is considered nonessential for
caveolae formation, since lack of cav2 does not affect ca-
veolae formation [39]. The western blot analysis showed
that SL pericytes express abundant cav1 and cav2 (Fig. 3)
but not cav3 (data not shown). The caveolins’ concentra-
tion was unaffected by the treatment from the lowest to
the highest of the GTM concentrations used (Fig. 3).
Gentamicin induced apoptosis in SL pericytes challenged
for 24 h
The apoptotic effect of GTM incubation on SL pericytes
was analyzed by simultaneously double staining the cells
with annexin-V and propidium iodide (PI) dye, distin-
guishing live cells, early stage apoptosis and late stage
apoptosis. Annexin preferentially binds phosphatidylser-
ine (PS), which in cell physiological condition is located
in the inner leaflet of the plasma membrane. In early
stage apoptotic cells, PS is translocated to the extracellu-
lar membrane leaflet where it is detected by fluores-
cently labeled Annexin V. Positive staining of chromatin
by PI occurs in the late stage apoptosis when the cell
membrane loses integrity allowing PI in the interior of
the cell. Data from the flow cytometer analysis are
shown in Fig. 4. The percentage of live cells population
showing a negative signal for either Annexin or PI stain-
ing, decreased significantly at the GTM concentration of
5 mg/ml (p = 0.049) and 10 mg/ml (p = 0.00079). The
Annexin positive PI negative population showed no sig-
nificance after 24 h of GTM incubation at any of the
GTM concentrations used. Cells treated with 10 mg/ml
Fig. 2 SL pericytes characterization. Flow cytometry analysis of cells obtained from the cochlear SL. The histograms show that 97.39% of the cells are
negative for the expression of vWF, a validated marker for endothelial cells. Cells show positive expression for validated pericyte markers Desmin
(68.4%), NG2 (48.2%), and α-SMA (84.1%). The detection of αSMA identifies pericytes from the SL, the only pericyte type in the microvasculature of the
lateral wall to express the contractile protein. In the figure black histograms identify the unstained cells, blue histograms identify the isotype control
and the red histograms identify the markers of interest
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GTM showed a significant increase (p = 0.0025) at late
stage apoptosis. The results showed that 24 h incubation
with GTM at the concentration of 10 mg/ml stressed the
cells, significantly inducing apoptosis. SL pericytes incu-
bated at lower GTM concentrations showed signs of
stress, such as a decrease in cell number, without a signifi-
cant increase of cell apoptosis. Based on these results, we
selected the concentration 5 mg/ml of GTM to stress the
cells without inducing a significant level of apoptosis, in
order to identify the specific proteome in challenged cells.
Analysis of the caveolae proteome in SL pericytes
Proteins segregating with caveolae extracted from control
and GTM-treated SL pericytes were analyzed by mass
spectrometry. Venn diagrams were used to visualize the
similarities and differences in the caveolae proteome in
GTM treated and untreated SL pericytes in the three mass
spectrometry experiments. Overall 3230 proteins were
identified considering all the control runs and 3902 pro-
teins considering all the GTM runs. 23.4% of proteins
were found common to all control runs and 22.5% of pro-
teins were found common to all GTM runs. In order to
obtain a stringent result and confidently identify the
uniquely expressed protein in control and GTM treated
datasets, proteins found in at least two of the three mass
spectrometry runs were considered for the bioinformatic
analysis. Proteins that only showed in one out of the three
mass spectrometry repeats either in control or in the
GTM dataset were removed, leaving 1682 proteins in the
control runs and 2379 in the GTM runs. Of these, 251
proteins (15%) uniquely segregated with caveolae in con-
trol, 948 proteins (40%) uniquely segregated with caveolae
in GTM, and 1431 proteins were common to both data-
sets [see Additional file 2].
Enrichment analysis of proteins segregating with
caveolae in gentamicin challenged cells
Protein encoding genes from the control and GTM-
treated datasets that appeared in two out of three mass
spectrometry repeats were considered for the enrich-
ment analysis. The GTM dataset was the target group
and the control dataset plus the GTM dataset, were
chosen as background group. Gene ontology terms with
q-value below 0.05 are listed in Tables 1A and B. The
Fig. 3 Caveolin-1 and caveolin 2 expression in SL pericytes is not
affected by gentamicin. Western blot analysis of whole cell lysate
from SL pericytes expressing caveoin-1 and cavolin-2. SL pericytes
were incubated with increasing concentration of GTM for 24 h. The
expression of cav-1 and cav-2 in the SL pericytes was not depleted
by the GTM treatment
Fig. 4 Gentamicin induced cell apoptosis is dose dependent. Box Plot graphs obtained from flow cytometry analysis of fluorescently labeled Annexin V and
propidium Iodide (PI) SL pericytes. Cells were incubated for 24 h at increasing concentration of GTM (1, 5 and 10 mg/ml). a The percentage of live cells
population showing a negative signal for either Annexin or PI staining, decreased significantly at the GTM concentration of 5 mg/ml (p< 0.049) and 10 mg/
ml (p< 0.00079). b The Annexin positive PI negative population showed no significance after 24 h of GTM incubation at any of the GTM concentrations used.
c Cell treated with 10 mg/ml GTM showed a marked significance (p< 0.0025) for late stage apoptosis. Data consisted of 4 independent experiments for
controls and 3 independent experiment for GTM treated cell. Differences between controls and treated cells were analyzed with one-way ANOVA followed
by a Dunnett’s test (9 degrees of freedom) when data showed significance. Differences were considered significant for p< 0.05. Statistical test were performed
with R version 3.3.1 (R core team) *p < 0.05, **p< 0.01 ***p< 0.001
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enrichment analysis was performed for the GO categor-
ies “Molecular function” which identify the molecular
activity of genes products, “Cellular component” which
indicates where gene products are active and “Biological
process” which identifies pathways and larger processes
comprising the activities of multiple gene products.
The category “Biological Process” (Table 1A) showed a
strongly significant enrichment for terms participating into
two groups. One group comprising the processes associated
with transport and localization, and the other comprising
terms referring to metabolic, bioenergetic and biosynthetic
processes. In the first group the highest significance was
Table 1 A and B. Enriched terms for the ontologies “Biological process” and “Cellular component” in gentamicin treated cells. Proteins that
appeared in two out of three mass spectrometry repeats were considered for the analysis. Proteins segregating with caveolae in the GTM
treated cells dataset where selected as the target for the GOrilla enrichment analysis. The control dataset plus the GTM dataset were chosen
as background group in the analysis. All terms with FDR q-value below 0.05 are listed in Tables 1A and B. (A) The GO category “Cellular
Process” showed significant enrichment for processes associated with transport and localization, and associated to metabolic, bioenergetic
and biosynthetic processes. (B) The GO category “Cellular component” showed significant enrichment for terms participating in three main
groups, one comprising terms referring to cell cytoplasm and organelles, the other comprising terms referring to extracellular components
and vesicles, and a third group comprising terms referring to cell membrane and membrane/protein interactions.
A GO biological process
GO term Description FDR q-value Enrichment (N, B, n, b)
GO:0044710 single-organism metabolic process 3.50E-06 1.07 (2597,532,2348,515)
GO:0044281 small molecule metabolic process 1.65E-05 1.09 (2597,323,2348,317)
GO:0045184 establishment of protein localization 9.64E-03 1.06 (2597,376,2348,362)
GO:0006810 transport 8.07E-03 1.05 (2597,709,2348,670)
GO:0015031 protein transport 1.23E-02 1.07 (2597,351,2348,338)
GO:0008104 protein localization 1.62E-02 1.06 (2597,431,2348,412)
GO:0055114 oxidation-reduction process 1.71E-02 1.08 (2597,214,2348,209)
GO:0051179 localization 1.85E-02 1.04 (2597,793,2348,745)
GO:0042592 homeostatic process 1.71E-02 1.08 (2597,193,2348,189)
GO:0043436 oxoacid metabolic process 1.85E-02 1.09 (2597,172,2348,169)
GO:0019752 carboxylic acid metabolic process 1.68E-02 1.09 (2597,172,2348,169)
GO:0006082 organic acid metabolic process 2.16E-02 1.08 (2597,187,2348,183)
GO:0051234 establishment of localization 2.27E-02 1.04 (2597,733,2348,689)
GO:0044711 single-organism biosynthetic process 2.62E-02 1.08 (2597,183,2348,179)
B GO Cellular component
GO term Description FDR q-value Enrichment (N, B, n, b)
GO:0044444 cytoplasmic part 1.91E-08 1.03 (2597,1603,2348,1499)
GO:0031982 vesicle 6.31E-07 1.05 (2597,1045,2348,988)
GO:0043230 extracellular organelle 7.51E-07 1.05 (2597,942,2348,893)
GO:1903561 extracellular vesicle 5.63E-07 1.05 (2597,942,2348,893)
GO:0070062 extracellular exosome 4.86E-07 1.05 (2597,941,2348,892)
GO:0031988 membrane-bounded vesicle 4.37E-07 1.05 (2597,1000,2348,946)
GO:0044421 extracellular region part 3.38E-06 1.04 (2597,982,2348,927)
GO:0098796 membrane protein complex 1.24E-05 1.09 (2597,272,2348,267)
GO:0044425 membrane part 1.25E-04 1.05 (2597,781,2348,738)
GO:0016020 membrane 4.63E-04 1.03 (2597,1470,2348,1363)
GO:0044432 endoplasmic reticulum part 2.25E-03 1.09 (2597,153,2348,151)
GO:0005829 cytosol 1.14E-02 1.05 (2597,397,2348,378)
GO:0031090 organelle membrane 2.65E-02 1.05 (2597,435,2348,412)
GO:0005783 endoplasmic reticulum 2.77E-02 1.06 (2597,312,2348,298)
GO:0005739 mitochondrion 2.82E-02 1.04 (2597,508,2348,479)
GO:0098588 bounding membrane of organelle 4.45E-02 1.06(2597,231,2348,222)
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reached by the terms “Transport” (GO:0006810; FDR
q-value 8.07X10− 3) and “Establishment of protein
localization” (GO: 0045184; FDR q-value 9.64X10− 3),
followed by the terms “Protein transport” (GO: 001
5031), “Protein localization” (GO:0008104), “Localization”
(GO: 0051179) and “Establishment of localization” (GO:
0051234) all with FDR q-value< 0.05.
In the second group, the highest significance was
reached by the terms “Single organism metabolic process”
(GO:0044710; FDR q-value 3.50X10− 6) and “Small mol-
ecule metabolic process” (GO:0044281; FDR q-value
1.65X10− 5) followed by the terms “Oxidation reduction
process” (GO:0055114), “Homeostatic process” (GO:004
2592), “Oxoacid metabolic process” (GO:0043436), “Car-
boxylic acid metabolic process” (GO:0019754), “Organic
acid metabolic process” (GO:0006082) and “Single or-
ganism biosynthetic process” (GO:0044711), all with
FDR q-value< 0.03.
Terms for GO “Cellular component” (Table 1B) showed
a strongly significant enrichment for terms participating
in three main groups: one group comprising the cell cyto-
plasm and organelles, another comprising terms referring
to extracellular components and vesicles, and finally, a
group comprising terms referring to cell membrane and
membrane/protein interactions. In the first group the
highest significance was reached by the term “Cytoplasmic
part” (GO: 0044444 FDR q-value 1.91X10− 8), followed by
the term “Endoplasmic reticulum part” (GO:0044432;
FDR q-value 2.25X10− 3). The terms “Cytosol” (GO:
0005829),“Organelle membrane” (GO:0031090), “Endo-
plasmic reticulum” (GO:0005783) and “Mitochondrion”
(GO:0005739) followed, all with a FDR q-value< 0.03.
In the second group, the highest significance was reached
by the terms “Extracellular organelle” (GO:0043230),
“Vesicle” (GO:0031982), “Extracellular vesicle” (GO: 1,903,
561), “Extracellular exosome” (GO:0070062), “Membrane
bounded vesicle” (GO:0031988) all with FDR q-value 10− 7
followed by the term “Extracellular region part” (GO:004
442 FDR q-value 3.38X10− 6).
In the third group, the highest significance was reached
by the term “Membrane protein complex” (GO:0098796
FDR q-value 1.24X10− 5) followed by the terms “Membrane
part” (GO:0044425) and “Membranes” (GO:0016020) FDR
q-value 10− 4, followed by the term “Bounding membrane
of organelle” (GO:0098588 FDR q-value 4.45X10− 2).
Interestingly, none of the terms in the category
“Molecular function” reached a statistically significant
enrichment (FDR q-value > 0.05).
The analysis of the enriched terms in the GTM dataset
confirms the activity of caveolae as a microdomain
mostly involved in protein transport and participating in
movement, localization and tethering of proteins to
membranes and vesicles in the cell cytosolic compart-
ments. In pathological conditions, such as when cells are
challenged with GTM, caveolae significantly participate
in pathways involving interactions with extracellular
vesicles, cytoplasmic vesicles and organelles, in particu-
lar directed toward endoplasmic reticulum and mito-
chondria. The enrichment of metabolic bioenergetic and
biosynthetic processes, together with the enrichment of
endoplasmic reticulum and mitochondria cellular com-
ponent, reveals the importance of caveolae participation
in the activation and maintenance of biosynthesis and
metabolic pathways when the cell undergoes to patho-
logical stress. These findings establish a new and import-
ant role for caveolae as essential microdomains for the
metabolism and biosynthetic processes in SL pericytes.
Enrichment analysis of proteins uniquely segregating
with caveolae in gentamicin challenged cells
In order to discover which categories were enriched in the
proteins specifically expressed during the GTM challenge
and suppressed in untreated cells, the 948 proteins uniquely
segregating with caveolae in the GTM dataset were chosen
as the target for the GOrilla enrichment analysis. Together,
the control and GTM datasets were used as background.
The GO terms were ranked in a table according to the FDR
q-value with value below 0.05 considered significant.
The enrichment of the protein encoding gene dataset
uniquely expressed in GTM challenged cells, reached sig-
nificance only in the GO category “Molecular function”
(Table 2). The GO terms, “Transferase activity transferring
phosphorus containing groups” (GO:0016772; FDR q-value
6.34X10− 3), “Transferase activity” (GO: 0016740; FDR
Table 2 Enriched terms in proteins uniquely segregating with caveolae in gentamicin challenged cells. The 948 proteins uniquely
segregating with caveolae in GTM treated cells where selected as the target group for the GOrilla enrichment analysis. The control
dataset plus the GTM dataset were chosen as background group. GO terms with a FDR q-value p < 0.05 were considered in the
table. “Molecular function” was the only in the GO category reaching significance. The majority of the proteins associated with the
enriched terms are involved in protein kinases activity
Molecular function
GO term Description FDR q-value Enrichment (N, B, n, b)
GO:0016772 transferase activity, transferring phosphorous-containing groups 6.34E-3 1.57 (2597.121, 932, 68)
GO:0016740 transferase activity 1.70E-2 1.32 (2597, 289, 932,137)
GO:0016773 phosphotransferase activity, alcohol group as acceptor 4.09E-2 1.60 (2597, 82, 932, 47)
Ghelfi et al. Proteome Science  (2018) 16:7 Page 10 of 26
q-value 1.70X10− 2), and “Phosphotransferase activity
alcohol group as acceptor” (GO:0016773; FDR q-value
4.09X10− 2) were significantly enriched in this category.
The majorities of the proteins associated with the
enriched terms are involved in protein kinases activity such
as, cyclic adenosine monophosphate (cAMP) dependent,
protein serine/threonine kinase activity, protein kinase C
(PKC), calmodulin (CaM) and mitogen-activated protein
(MAP) kinases and proteins involved in cysteine endopep-
tidase activity. The protein kinases listed regulate several
aspects of cell functionality. Represented functions span
from transport activities such as endocytosis and Rab pro-
teins trafficking to regulation of cell cycle control, progres-
sion, arrest and volume control. Represented functions
regulate cell proliferation, motility and morphology, cyto-
skeletal reorganization, expression of stress fibers, cell adhe-
sion and nuclear signaling. Represented are also kinases
active in inflammation and apoptosis processes such as
MAPK, c-Jun N-terminal kinase (JNK) signaling pathways,
transcription factors such as NFkB (nuclear factor kappa-
light-chain-enhancer of activated B), proinflammatory cyto-
kines, protein involved in the inflammasome assembly and
in apoptotic pathways. The list includes also kinases partici-
pating in the calcium metabolism and proteins participating
in the cell energy metabolism, in metabolism control and in
glycolysis, such as hexokinase glycolytic enzymes, energy
reduction sensing enzymes adenosine monophosphate-
activated protein kinase (AMPK) and proteins participating
in the regulation of lipid metabolism and lipid synthesis,
catabolism control, autophagy and cell growth.
These data show cells boost pathways for cell survival
and apoptosis that and may enhance metabolism and
biosynthesis in an attempt to maintain the cell function-
ing and survival during GTM exposure. Furthermore
these data show caveolae acting together with cell
kinases to activate pathways that are essential for cells
vital processes during GTM exposure.
Enrichment analysis of proteins uniquely segregating
with caveolae in untreated cells
In order to discover which GO categories were suppressed
when cell were exposed to GTM, the 251 protein encoding
genes uniquely segregating with caveolae in the control
dataset were chosen as the target. For this analysis, together,
control and GTM datasets were used as background. All
terms with FDR q-value below 0.05 were considered
significant. Data are presented in Tables 3A, B, C where
GO terms reaching a significant enrichment up to FDR
q-value of 10− 5 are listed. The full list of significantly
enriched terms is presented in the additional files [See
Additional file 3].
The enrichment showed significance for terms in the cat-
egories “Biological process”, “Cellular component” and
“Molecular function” (Tables 3A, B, C and Additional file 3).
The category “Biological process” (Table 3A) showed a
strongly significant enrichment for terms participating into
two main groups. The first one comprising metabolic pro-
cesses with the higher significance for the terms “Nucleic
acid metabolic process” (GO:0090304; FDR q-value 2.59X10
− 10) and “RNA metabolic process” (GO:0016070; FDR q-
value 3.1X10− 10), followed by the terms “Nucleobase-con-
taining compound metabolic process” (GO:0006139), “Het-
erocycle process” (GO:0046483) “Cellular aromatic
compound metabolic process” (GO:0006725), and “RNA
biosynthetic process”, all of them with a FDR q-value 10− 5.
The second group comprises proteins involved in transcrip-
tion and genetic information processing such as the terms
“Regulation of gene expression” (GO:0010468), “Transcrip-
tion DNA template” (GO:0006351), and “Nucleic acid tem-
plate transcription” (GO:0097659) and “RNA processing” all
of them with a FDR q-value 10− 5.
The ontology “Cellular component” (Table 3B) had the
higher enrichment for the terms.
“Nuclear part” (GO:0044428; FDR q-value 1.15X10− 6)
and “Nucleus” (GO:0005634; FDR q-value 4.66X10− 6).
Proteins grouped under the terms accounted mainly for
proteins active in the spliceosomal complex.
The ontology “Molecular function” had significantly
enriched terms involved in RNA and DNA binding. The
higher significance was reached by the terms “Nucleic acid
binding” (GO:0003676; FDR q-value 5.68X10− 10) followed
by the terms “DNA binding” (GO:0003677; FDR q-value
1.58X10− 7), “Regulatory region nucleic acid binding”
(GO:0000975), “Transcriptional regulatory region DNA
binding” (GO:0044212), and “Regulatory region nucleic
acid binding” (GO:0001067), with a FDR q-value 10− 7.
The term “Sequence-specific DNA binding” (GO:004
3565) and “Sequence-specific double stranded DNA bind-
ing” with FDR q-value 10− 5. The major difference showed
by the enrichment analysis in the untreated cells versus
the GTM exposed cells is that a bulk of activities involving
genetic information processing, occurring between the
nucleus and cytoplasmic parts were suppressed. The gen-
etic information processing is mainly represented by the
spliceosome activity, DNA/ RNA metabolic processes
positive/negative regulation of DNA templates, RNA spli-
cing, and ribonucleoprotein activities. These pathways are
significantly suppressed once the cells were exposed to
GTM. Quite interestingly, these findings may show the
important role of caveolae in transferring genetic informa-
tion from the nucleus to the cytoplasm participating in
the cell genetic information processing. The data show
also the versatility of usages of caveolae by the cells in
physiological or pathological conditions, switching the
main activities from nucleus associated and cytoplasm
transport, to participating in energy metabolism and acti-
vation of pathways under stress conditions.
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Proteomaps of proteins uniquely segregating with
caveolae in control and gentamicin exposure cells
In order to visualize the differences between the proteins
uniquely expressed in control and GTM exposed cells and
in order to confirm the results obtained in the enrichment
analysis with an additional bioinformatic tool, we uploaded
the 948 and 251 proteins from the control and GTM data-
sets respectively to the web-available interactive software
Proteomaps (Fig. 5 and Additional file 4). First, the gene
names from the mass spectrometry runs were looked up in
UniProt / KEGG Orthology (mouse, 26,008 entries) to get
gene IDs acceptable to the mouse branch of Proteomaps.
Areas in the Proteomaps are proportional to the number of
proteins in the category as represented in the modified
KEGG orthology. To create a Proteomap, a total area is first
divided into color-coded polygons representing the top-
level categories.The top-level category areas are then subdi-
vided into subcategories where functionally related proteins
share common regions. All proteins entered in the Proteo-
maps analysis were given an arbitrary quantity value = 1. In
the control dataset 39 out of 251 proteins were not recog-
nized by the KEGG orthology. From the 212 submitted
proteins, 178 were supported by Proteomaps treemap, cor-
responding to 77% coverage. In the GTM dataset 99 out of
948 proteins were not recognized by the KEGG orthology.
From the 849 submitted proteins 599 were supported by
Proteomaps treemap, corresponding to 70.6% coverage.
In the control top-level areas of the Proteomaps the
category “Genetic information processing” had the largest
polygon (Fig. 5a). In the control the polygons representing
“Metabolism”, “Cellular processes” and “Environmental
processes” were smaller and similar in size. In GTM ex-
posed cells (Fig. 5c) the Proteomaps visualization showed
a dramatic difference in the polygon sizes as compared to
the control sizes. In the top-level areas the polygons
“Metabolism”, “Cellular processes” and “Environmental
Table 3 A, B and C. Enrichment analysis of proteins uniquely segregating with caveolae in untreated cells. The 251 proteins uniquely
segregating with caveolae in untreated cells where selected as the target group for the GOrilla enrichment analysis. The control dataset
plus the GTM dataset were chosen as background group. GO terms with a FDR q-value p < or = 10− 5 were considered in the table. The
complete list of significantly enriched GO terms to p < 0.05 is presented as additional file [See Additional file 3]. The enrichment showed
significance for terms in the categories “Biological process”, “Cellular component” and “Molecular function”. The enriched terms showed
the suppressed activities and functions in the cells once GTM is administered.
A Biological process
GO term Description FDR q-value Enrichment (N, B, n, b)
GO:0090304 nucleic acid metabolic process 2.59E-10 1.96 (2597,537,249,101)
GO:0016070 RNA metabolic process 3.1E-10 2.06 (2597,455,249,90)
GO:0006139 nucleobase-containing compound metabolic process 1.86E-5 1.61 (2597,673,249,104)
GO:0046483 heterocycle metabolic process 4.34E-5 1.57 (2597,704,249,106)
GO:0006725 cellular aromatic compound metabolic process 6.41E-5 1.56 (2597,694,249,104)
GO:0006351 transcription, DNA-templated 7.04E-5 2.23 (2597,210,249,45)
GO:0097659 nucleic acid-templated transcription 6.03E-5 2.23 (2597,210,249,45)
GO:0010468 regulation of gene expression 7.14E-5 1.66 (2597,539,249,86)
GO:0032774 RNA biosynthetic process 8.61E-5 2.19 (2597,214,249,45)
GO:0006396 RNA processing 9.71E-5 2.13 (2597,230,249,47)
B Cellular component
GO term Description FDR q-value Enrichment (N, B, n, b)
GO:0044428 nuclear part 1.15E-6 1.54 (2597,855,249,126)
GO:0005634 nucleus 4.66E-6 1.38 (2597,1160,249,154)
C Molecular function
GO term Description FDR q-value Enrichment (N, B, n, b)
GO:0003676 nucleic acid binding 5.68E-10 1.70 (2597,779,249,127)
GO:0003677 DNA binding 1.58E-7 2.36 (2597,243,249,55)
GO:0000975 regulatory region DNA binding 8.02E-7 3.56 (2597,79,249,27)
GO:0044212 transcription regulatory region DNA binding 6.01E-7 3.56 (2597,79,249,27)
GO:0001067 regulatory region nucleic acid binding 9.13E-7 3.48 (2597,81,249,27)
GO:0043565 sequence-specific DNA binding 1.34E-5 3.09 (2597,91,249,27)
GO:1990837 sequence-specific double-stranded DNA binding 4.73E-5 3.48 (2597,63,249,21)
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information processes” double in size as compared to the
control polygons, while the polygon “Genetic information
processes” in the GTM top-level area (Fig. 5c) dramatic-
ally decreases as compared to the same category in the
control dataset.
The subdivision of the top-level areas into subcategor-
ies in Figs. 5b and 4d, shows more detailed information
of the processes affected and enhanced in control and
GTM exposed cells. GTM exposure dramatically sup-
press the proteins participating in the subcategories
“Translation”, “Transcription” and “DNA maintenance”,
while “Folding sorting and degradation” processes (within
the “Genetic information processes” top polygon) double
in size as compared to the control. Furthermore, the sub-
categories “Biosynthesis” and “Central carbon metabol-
ism” double their size in GTM exposed cells as compared
to control and a new sub-category, “Energy metabolism”,
was detected. GTM affects cell signaling; in the top area
“Environmental information processing”, the subcategory
“Signal transduction” and “Signaling molecule and inter-
action” double in size as compared to control. Finally,
GTM exposed cells enhanced vesicular transport. In top
area “Cellular processes” the subcategory “Vesicular trans-
port” doubles in size as compared to control and the sub-
category “Cell growth and death”, not represented in
control, appeared.
These results confirm the previously obtained results
using the GOrilla enrichment analysis. Overall, the GTM
exposure resulted in a dramatic decrease in the genetic
information processing and a dramatic increase in cell
metabolism both aerobic and anaerobic, and an increase in
biosynthesis, signal transduction and vesicular transport.
Fig. 5 Comparative visualization of the proteins uniquely segregating with caveolae in control and gentamicin treated cells. Panels a and c show the top
level area polygons for control and GTM datasets respectively. Panels b and d, show the division of the top area polygons in sub-categories for the two
datasets. The visualization shows a dramatic difference in the polygon sizes in GTM treated vs control cells. The “Genetic information processing” polygon
shows a reduction of “Translation”, “Transcription” and “DNA maintenance” processes and an increase in the “Sorting folding and degradation processes”. All
the sub-categories in the “Metabolism” polygon double the size in GTM treated cells as compared to the untreated ones and a new subcategory “Energy
metabolism” appeared. The doubling in size of the “Cellular processes” in GTM treated cells, mostly accounts for by the increase of the “Vesicular transport”
process and the introduction of a new subcategory “Cell growth and death”. The subcategory “Signal transduction”, accounts for the increase of the top area
Environmental information processes. Control and gentamicin top area polygons panel A and C in the figure, from the top left corner clock
wise are: Environmental information processes, Genetic information processes, Cellular processes, Metabolism, Organismal system, Human diseases. Control:
Subcategories panel B from the top left corner clock wise are: Signaling molecule and interaction, Signal transduction, translation, DNA maintenance,
Folding sorting and degradation, Transcription; Vesicular transport cellular community cytoskeleton; Other enzymes, Central carbon metabolism, Biosynthesis,
Membrane transport; Digestive system, Immune system, Endocrine system; Cancer, Infectious diseases. Gentamicin: subcategories panel D, from the top left
corner clock wise are: Signal transduction, Signaling molecule and interaction; Translation, DNA maintenance, Folding sorting and degradation, Transcription;
Cell growth and death, Vesicular transport Cytoskeleton, Cellular community; Other enzymes, Central carbon metabolism, Biosynthesis, Membrane transport
Energy metabolism; Nervous, Excretory, Circulatory, Digestive, Immune, Endocrine systems, Development; Cardiovascular, Infectious diseases Cancer, Immune
and Neurodegenerative diseases
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These outcomes, together with the representation the sub-
category “Cell growth and death”, suggest that cells are
responding to stress and activating survival mechanisms,
which include increase in biosynthesis, energy metabolism,
and proteins degradation on one side, and apoptosis on the
other. GTM dramatically reduced the number of proteins
involved in transcription and DNA maintenance activities.
The increase in vesicular transport showed that caveolae is
a major player in all of those processes. Finally, the similar-
ity of the results obtained in the two distinct bioinformatic
analyses, Proteomaps and GOrilla, confirm the robustness
of these results.
Transporter Rab GTPases segregating with caveolae in
the SL pericytes
The bioinformatic analysis showed that the GTM exposure
boosted the vesicular transport in SL pericytes. We then
focused our attention on Rab GTPases a group of trans-
porter proteins often found associated to the caveolae and
known to regulate trafficking in all cellular compartments.
Table 4 shows all the Rab proteins segregating with caveo-
lae in each of the three mass spectrometry repeats for con-
trol and GTM exposed cells. In the whole caveolae
proteome obtained from the three mass spectrometry
repeats, 36 Rab proteins were found associated with caveo-
lae in the control dataset and 49 Rab proteins were associ-
ated with caveolae in the GTM dataset. Fourteen Rab
proteins, shown in red under the GTM columns: Rab3b,
Rab3d, Rab3gap1, Rab3ip, Rab12, Rab22a, Rab24, Rab29,
Rab32, Rab 34, Rab 39b, Rabgef1, Rabggta, and Rabl3 were
found uniquely expressed in the GTM exposed cells. Only
one protein, Rab39a, was uniquely expressed in the control
cells. An enrichment analysis was performed in order to
understand if the GTM exposed cells were significantly
enriched for the Rab proteins. Rabs appearing in two out of
three mass spectrometry repeats were selected. The enrich-
ment was determined using the hypergeometric function in
R, phyper, for the pool of proteins in control and exposed
cells. The pool of Rab proteins expressed in the caveo-
lar fraction during the GTM challenge was significant
with p = 0.032. While the pool of Rab proteins
expressed in the control proteome of caveolae was not
significantly enriched (p = 0.78). Figure 6 shows the
localization and the interactions of the transporter Rab
proteins with the cytoplasmic and membrane compo-
nents in the cell. The figure is based on the Uniprot de-
scriptions of the corresponding Rab proteins.
Rab proteins segregating with caveolae in the three
mass spectrometry (MS) experiments are listed in the
table. The UniProt identifiers are given in the table for
each Rab protein as well as the highest number of
unique peptides (n) identifying the proteins. Black char-
acters are Rabs segregating with caveoale in both GTM
treated and untreated cells. Rab proteins found only in
the GTM dataset are represented with red characters
and the Rab protein found only in the control dataset is
represented with blue.
Overall, the data shows that Rab proteins segregating
with caveolae are involved in trafficking from the cell
membrane to the endosomes network, from the endo-
somes to the lysosome and the autophagosome, and
between the endoplasmic reticulum and the Golgi vesi-
cles. Rabs represented are also involved in exocytosis,
transcytosis and in secretory vesicles, transport to mito-
chondria and phagosome. Interestingly, Rabs uniquely
found in GTM challenged cells participate in exocytosis
pathways (Rab3b and Rab3d), in the phagocytic pathway
(Rab32 and Rab34) and transport to mitochondria
(Rab32 and Rab3A), in pathways involving trafficking
from cell membrane to endosomes (Rab3b and Rab22a),
in Golgi trafficking to cell membrane and endocytic
pathways (Rab39b and Rab29), in trafficking from late
endosome to lysosome and autophagosome pathways
(Rab24, Rab12, Rab34) and finally in transport in the
perinuclear area (Rab3ip and Rab3b). The functions and
localizations of a few Rabs segregating with caveolae
expressed in both datasets (Rabif and Rabl6) and segre-
gating only in GTM dataset (Rabl3, Rabggta, Rab3gap1)
are unknown.
GTM exposure significantly enhanced the Rabs associ-
ated with caveolae in GTM exposed vs control cells. The
segregation of specific Rab proteins with caveolae in GTM
exposed cells suggests a change in trafficking toward spe-
cific pathways. Rab proteins associated with caveolae in
GTM treated cells have functional activity with the autop-
hagosome and the lysosome pathways, showing a prefer-
ence in the activity of Rab transport toward protein
degradation and endosomal trafficking. GTM exposure
enhanced the Rab proteins trafficking from the cell mem-
brane to endosomal network, to the recycling endosome
and toward exocytosis. Pathways of Rab proteins trafficking
toward and from the Golgi apparatus and in the mitochon-
drial network and perinuclear area were also represented.
The increased association of Rab proteins with caveolae in
GTM exposed cells and the significant enrichment of the
pool of Rabs expressed in the GTM exposed may be used
as a marker for cellular stress.
Rab proteins immunoblotting quantification
A pool of Rab proteins was selected for immunoblot
quantification from the list of the Rabs isolated with ca-
veolae and identified with LC MS/MS. Rabs selected for
the analysis were chosen based on larger presence of a
specific Rab protein in the GTM group versus the con-
trol group in the six LC MS/MS runs, as shown in
Table 4. The Rab proteins selected were Rab3a, Rab3b,
Rab3gap2, Rab4, Rab5, Rab6a, Rab6b, Rab7, Rab8a,
Rab9, Rab11, Rab13, Rab22a, Rab23.
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The analysis was conducted to investigate concentra-
tion effects of GTM treatment on Rab proteins involved
in vesicular trafficking and associated with caveolae. The
concentration of four Rab proteins expression varied sig-
nificantly upon GTM treatment. Rab 8a, Rab13 and
Rab3gap2 significantly decreased at GTM concentration
of 5 mg/ml; Rab9a significantly increased at 1 mg/ml
GTM concentration (Fig. 7).
The Uniprot database lists Rab8a activity in polarized
vesicular trafficking, autophagy and neurotransmitter
release, furthermore Rab8 activity has been described in
transcytosis, in ciliogenesis and in the regulation of ad-
herent junctions assembly [40]. Interestingly Rab8 has
been described in two studies involving in hearing loss.
The first [41, 42], has been recognized as a binding part-
ner of otoferlin a protein found in ribbon synapses,
Table 4 Rab proteins segregating with caveolae in the mass spectrometry analysis in gentamicin treated and untreated cells
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sensory hair cells and neurons in the cochlea as well
as co-localizing with endosomal and Golgi proteins.
Mutation in OTOF encoding otoferlin leads to a non-
syndromic deafness named autosomal recessive deaf-
ness 9 (DFNB9). The second study [43] identifies Rab8
as partner recruited by the BBSome complex of
Bardet-Biedel syndrome (BBS) protein family to promote
ciliary biogenesis. Mutations in the BBsome complex in-
duces the Bardet-Biedel pleiotropic syndrome character-
ized, among other pathologies, by acute and chronic otitis
media, resulting in conductive hearing loss in early child-
hood [44].
Rab9a participates in the transport of proteins between
the endosomes and the trans-Golgi network [45–47].
This function is of interest given the presence of mel-
anin granules in the spiral ligament fibrocyte and the
high concentration of melanine granules in the inter-
mediate cells. Rab9a is required to regulate the process
of unconventional alternative autophagy [48, 49] and
mitophagy [50]. Rab13 regulates membrane trafficking
between the trans-Golgi network and the recycling en-
dosome [51]. It also regulates tight junctions’ activity,
endothelial cells angiogenesis and autophagy [52, 53].
The hydrolysis of Rab-GTP is GTPase activating pro-
tein (GAP)-assisted and regulates Rab proteins activity
in vesicular trafficking. Rab proteins switch between the
guanosine diphosphate (GDP)-bound conformation and
the GTP-bound conformation. Rab-GTPase activating
proteins (RabGAPs) encourage the Rab proteins to
hydrolyze the bound GTP then by the action of a second
protein interaction partner, a guanine nucleotide ex-
change factor (GEF), the GDP can be swapped for GTP.
[54, 55]. Rab3gap2 is a regulatory subunit specific for
the Rab3 subfamily which is involved in exocytosis, in
synaptic and non-synaptic vesicular release of neuro-
transmitters and hormones and in proliferation, migra-
tion and differentiation processes. Furthermore the
heterodimeric Rab3Gap1 and Rab3gap2 complex has
been shown to modulate autophagosomal biogenesis to
influence protein aggregation and to affect autophagy at
basal and rapamycin-induced conditions [56].
Finally, the protein concentration measurements in
the immunoblots for Rab3a, Rab3b, Rab4, Rab5, Rab6a,
Rab6b, Rab7, Rab11, Rab13, Rab22a, Rab23 did not
reach significance and are shown as supplemental mater-
ial (Additional files 5 and 6).
Fig. 6 Rab proteins segregating with caveolae in control and gentamicin challenged cells. All Rab proteins appearing in the 3 MS runs are shown
in the map. Black characters are Rabs segregating with caveolae in both GTM treated and untreated cells. Rab proteins found only in the GTM
dataset are represented with red characters. The Rab protein segregating with caveolae only in the untreated cells is represented with blue
character. Functions and localization of Rabs in the box on the lower right are unknown or inferred. Rab proteins localization and function in the
map are based on the UniProt description. Secretory vesicles (SVs); transcytosis (T) autophagosome (AF); phagocytosis (PH)
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Nonsyndromic hearing loss proteins segregating with
caveolae in SL pericytes
In a previous study it has shown that nonsyndromic path-
ologies related proteins were associated with cholesterol-
rich microdomains [25]. Mutated gene products inducing
nonsyndromic pathologies have been described in various
tissues and cell types in the inner ear. Overall in this
study, we found fifteen proteins previously described
in nonsyndromic hearing loss pathologies segregating
with caveolae in SL pericytes (Table 5).
Four of these proteins MYH14, MYH9, WFS1 and
KARS have been previously described in the SL. MYH14
is a motor protein with poorly understood functions while
the MYH9 protein plays a role in cytokinesis, cytoskeleton
reorganization and focal contact formation. WFS1 encode
for a protein participating in the regulation of cellular Ca2
+ homeostasis. Finally, KARS derived protein is known to
interact with laminin receptor on the cell surface and
catalyze specific attachment of amino-acid to its cognate
tRNA [57]. The remaining eleven proteins were identified
for the first time in SL pericytes. Eight proteins were
found expressed both in controls and GTM exposed cells.
The group comprises RXD, TRIOBP, MYO6, SERPINB6,
Tjp2, DIAPH1, PNP1 and TPRN. One protein, CIB2, was
found to be exclusively expressed in control SL pericytes
and two proteins, MSRB3 and CCDC50, were found
exclusively in GTM exposed cells. CCDC50 encoded pro-
tein is involved in epidermal growth factor receptor
(EGFR) signaling, while MSRB3 is an antioxidant enzyme
that catalyzes the reduction of free and protein-bound me-
thionine sulfoxide to methionine. MSRB3 is an essential
protein for hearing since it has been shown that its abla-
tion in MSRB3−/− mice cause profound hearing loss with-
out other pathological symptoms [58].
Discussion
Crossing the BLB is necessary for GTM to penetrate any
cells of the inner ear [8–11]. Delivery across the BLB is
also a potential route for therapeutic intervention in






































































































Fig. 7 Concentration effect of GTM on Rab proteins in SL pericytes. SL pericytes were incubated with increasing concentrations of GTM (1 mg/ml,
5 mg/ml,10 mg/ml GTM) for 24 h. Immunoblots were obtained for each Rab protein from the whole cell lysate. Protein quantification is expressed as
the relative quantity to the control for each Rab. Each graph is the result of n = 6 independent experiments for Rab8a (a) and Rab13 (c) and n = 4
independent experiments for Rab9 (b) and Rab 3gap2 (d). SEM was calculated for each group. Two tailed, paired Student’s ttest was used for statistical
analysis with significance set to p < 0.05
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noise. In view of these considerations, SL pericytes and
caveolae isolated from these cells provide and effective
and appropriate model to investigate changes in protein
transport induced by GTM and/or noise. SL pericytes
maintain the BLB in the lateral wall [8] of the inner ear.
Microvessels in this region have the highest ratio of peri-
cyte/endothelial cell of any microvascular bed in the
body [38]; they control the blood flow that is necessary
for the maintenance of inner ear perilymph and endo-
lymph [14, 15], whose chemical composition is essential
for hearing. SL pericytes are very similar to brain peri-
cytes, which have been shown to control endothelial
cells’ transcytosis [16], one of the important functions of
caveolae. Caveolae modulate cellular traffic to many cell
compartments, from the plasma membrane to endo-
somes to organelles [17–19] and this makes caveolae
and the proteins associated with them important for
investigating protein transport in pathological condi-
tions. Acoustic trauma and GTM have been shown to
damage the BLB [11, 12]. Our findings using this model
show that GTM induces significant changes in the net-
work of caveolae associated Rab transport proteins, with
potential impact on BLB physiology and hearing loss.
Indeed our results demonstrate that GTM exposure
altered SL pericytes proteomic profile in caveolae. The
finding of proteins uniquely segregating with caveolae
and the finding of a specific pattern of Rab proteins
association with caveolae during the GTM exposure rep-
resents a formidable target for therapeutic intervention
to the hardly accessible cochlear tissues.
This study shows that 40% of total proteins segregating
with caveolae are specifically expressed during GTM expos-
ure, and 15% of the proteins normally expressed in controls
are suppressed in cells incubated with GTM. Overall the
enrichment analysis showed that GO categories containing
proteins participating in energy metabolism regulation,
cytoplasmic transport, cell survival, apoptosis, protein syn-
thesis and degradation were significantly overrepresented in
the GTM exposed cells while GO categories including
proteins participating in genetic information were sup-
pressed during the exposure. Transport-specialized Rab
proteins were significantly enriched in the GTM ex-
posed cells.
Immunobloting analysis revealed a significant change
in Rab8a, Rab9a, Rab13, and Rab3gap2 protein concen-
tration in treated cells, suggesting a possible change in
cellular cargo transport under GTM treatment. Under-
standing the strong cooperation of caveolae and Rab
proteins in cytoplasmic trafficking and the trafficking
direction of caveolae cargoes away from degradation or
Table 5 Proteins associated with Non-Syndromic Hearing Loss segregating with caveolae in SL pericytes. The table shows proteins
implicated in nonsyndromic hearing loss pathologies segregating with caveolae in treated and untreated cells. The highest number
of unique peptides identifying the proteins is given in the table (n CTRL and n GTM) as well as their UniProt identifiers. The proteins
myosin heavy chain 14 (MYH14), myosin heavy chain 9 (MYH9), Wolframin (WFS1), Lysyl-tRNA synthase (KARS) have been previously
described in the SL. The proteins Diaphanous 1 (DIAPH1), MYH14, MYH9, unconventional myosin VI (MYO6), Radixin (RXD), TRIO and
filamentous actin binding protein (TRIOBP), Taperin (TPRN), WFS1, KARS, Serpin B6 (SERPINB6), tight junction protein ZO-2 (Tjp2),
polyribonucleotide-nucleotidyl transferase (PNP1), segregated with caveolae in both in untreated and GTM treated cells. One protein,
Calcium integrin-binding family member 2 protein (CIB2), exclusively segregated with caveoale in untreated cells and two proteins
Methionine Sulfoxide Reductase B3 (MSRB3) and Coiled Coil Domain Containing protein 50 (CCDC50) segregated exclusively in GTM
treated cells
Protein name Gene Function n CTRL n GTM UniProt ID
Diaphanous 1 DIAPH1 Cytoskeleton and mobility 4 5 O08808
Myosin Heavy Chain14 MYH14 Motor protein 2 2 Q6URW6
Myosin Heavy Chain9 MYH9 Motor protein 100 108 Q8VDD5
Unconventional myosin 6 MYO6 Motor protein 6 11 Q64331
Radixin RDX Cytoskeleton 6 10 P26043
TRIO filamentous actin binding protein TRIOBP Cytoskeleton 12 12 Q99KW3
Taperin TPRN Cytoskeleton 6 6 A2AI08
Wolframin WFS1 Regulation of Ca2+ homeostasis 14 14 P56695
Lysyl-tRNA-synthase KARS Attach amino-acid to its cognate tRNA 9 9 Q99MN1
Serpin B6 SERPINB6 Protease inhibitor 10 11 Q60854
Tight junction protein ZO-2 TJP2 Role in tight and adherents junctions 3 3 Q9Z0U1
Polyribonucleotide-nucleotidyl transferase PNPT1 Degrades mRNA 2 1 Q8K1R3
Calcium integrin binding protein 2 CIB2 Calcium-binding regulatory protein 1 Q9Z309
Methionine R sulfoxide reductase MSRB3 Antioxidant 2 Q8BU85
Coiled coil domain containing protein CCDC50 Cytoskeleton 2 Q810U5
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recycling inside the cells is important for successful drug
delivery to the inner ear.
Finally, we report here, a specific pattern of proteins
implicated in non syndromic pathologies segregated with
caveoale. Interestingly a protein essential for hearing
(MSRB3) is segregating with caveolae only in the GTM
exposed cells, underlining the importance of the antioxi-
dant defense in the inner ear and opening to the possi-
bility for therapeutic intervention through caveolae.
Caveolins had been identified as relevant in a non syn-
dromic pathology linked to hearing loss. Mutations in
GJB2, which encodes connexin26, a cochlear gap junction,
cause pre-lingual nonsyndromic deafness. Abnormal accu-
mulation of cav1-rich, and cav2-rich vesicles at the gap
junctions level, characterized by increased endocytosis
and junction disruption, was considered the underlying
cause of the pathology [27]. Increased cav2 accumulation
in GJB2 mutant mice has been associated with abnormal
morphology of the outer hair cells in the organ of Corti.
The increased cav2 level contributed dramatically to the
progression of the GJB2 –associated deafness [59]. Rab
proteins have also been linked to other proteins involved
in nonsyndromic deafness. Rab 8b has been recognized as
a binding partner of otoferlin, a member of the ferlin fam-
ily transmembrane anchored proteins whose mutations
cause nonsyndromic deafness due to defective neurotrans-
mission. Ferlins of the type-II sub-family, which include
otoferlin, localize in the trans-Golgi/recycling network.
One member of the sub-family colocalizes with cav3 in
endosomes of mouse and human myoblasts [60].
GTM offers an excellent model for studying hearing loss
induced by drugs and noise, since both causes have in free
radicals, one of the major initiators. Drug-induced and
noise-induced hearing losses are the leading causes of
hearing impairment and deafness in the world population.
The molecular mechanism leading to ototoxicity is not
fully elucidated, but reactive oxygen species ROS have
been recognized as one of the major culprits. GTM and
the related aminoglycoside antibiotics chelate iron, and
the resulting iron-aminoglycoside complex is redox-active,
catalyzing the formation of ROS [61]. Moreover, increased
oxidative stress is associated with both continuous and
impulse noise-induced hearing impairment [62, 63]. ROS
are considered one of the main culprits for noise-induced
hearing loss and deafness. Scientific evidence accumulated
since the 1990s shows the appearance of increased ROS
and other toxic free radicals, such as superoxide O2
-· or
lipid peroxides, during and after noise exposure [64]. Anti-
oxidants and iron chelators have been shown to protect
against both GTM-induced and noise-induced hearing
loss. Administration of alpha lipoic acid, a powerful anti-
oxidant and iron chelator, decreases aminoglycoside
induced hearing loss in vitro and in vivo [65, 66]. In hu-
man subjects, pretreatment with alpha lipoic acid has been
shown to protect from prolonged acoustic trauma [67].
Moreover, treatment with the antioxidant N-acetyl–cyst-
eine (NAC), a glutathione precursor and an antioxidant,
and the free radical scavenger agent disodium 2,4-disulfo-
phenyl-N-tert-butylnitrone (HPN-07), effectively reduced
hearing loss and cochlear hair cell death in rats, when ad-
ministered after blast exposure [63]. NAC has been shown
to reduce noise-induced hearing loss in animal models
exposed to continuous noise [68, 69] to protect human
subjects from noise-induced cochlear injury in clinical tri-
als [70, 71] and to improve GTM-induced ototoxicity in
hemodialysis patients [72]. SL pericytes are key cells for
studying the damage induced by aminoglycosides and by
noise in the cochlear microvasculature. Synergy and sig-
naling between endothelial cells and pericytes is funda-
mental for the maintenance of the blood labyrinth barrier
BLB [8]. A damaged BLB may be an entrance route for
ototoxic drugs. Hypotheses have been raised about vascu-
lar aminoglycoside trafficking through the spiral ligament
microvasculature and tissue, reaching the endolymph and
ultimately the cochlear hair cells [73]. Leaking capillaries
and loss of strong association of pericytes with endothelial
cells have been shown in the SV of animals exposed to
continuous acoustic trauma [74]. SL pericytes encircle
endothelial cells in the microvasculature of the SL in a 1:1
to 1:2 ratio, which is similar only to the micro-vessels of
the retina 1:1, and the brain 1:5; this is an extremely high
ratio compared to most other organs such as the lungs
1:10 and the skeletal muscle 1:100 [38]. The intimate
contact with the endothelial cells in the spiral ligament
microvasculature, suggests a central role for SL pericytes
as a bridge between the blood flow, the endothelial cell
and the inner ear tissues, suggesting the possibility of
intense signaling and metabolite exchange between the
two cell types. An important role for SL pericytes is the
control of the blood flow in the inner ear microvascula-
ture. SL pericytes contrary to the stria vascularis pericytes,
express contractile proteins such as α-SMA, and have
shown contractility in response to stimuli in vitro and in
vivo [14, 38]. The ability to contract allows the SL peri-
cytes to regulate the blood flow of the more distal down-
stream capillaries leading to the SV, [14], This is a critical
feature for generating the endocochlear potential, which is
indispensable for normal hearing [15]. Pericytes partici-
pate in transport across microvasculature, although the
role of pericytes in transport and transcytosis in the BLB
has been minimally investigated. Early reports described
SL pericytes and the BLB sharing similarities with the
brain pericytes and with the BBB respectively [75]. A
recently published work reported the importance of
pericytes in the critical control of endothelial cell transcyto-
sis in the brain microvasculature. The Mfsd2a (major-facili-
tator superfamily domain-containing-2a) protein-encoding
gene is selectively expressed in the BBB microvessels. The
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genetic ablation of Mfsd2a dramatically increases endothe-
lial cell vesicular transcytosis in KO mice, and the transcy-
tosis in endothelial cells, is controlled by pericytes, through
the modulation of Mfsd2a expression [16]. Because of the
similarity of the spiral ligament capillaries to the BBB
capillaries, it is plausible to speculate a similar regulatory
role for SL pericytes in the control of endothelial cells
transcytosis in the BLB. Understanding vesicle transport
and transcytosis in SL pericytes can shed light on metabol-
ite uptake and transport through inner ear microvascula-
ture in physiological and pathological situations.
Transcytosis and endocytosis are some of the functional
roles of caveolae, specialized and morphologically distinct,
cholesterol sphingolipids and protein-rich microdomains,
stabilized by caveolin proteins [76]. Caveolae are an
entrance point to the cell for albumin [77], bacteria,
viruses [78], DNA-linked peptides and cross-linked
polymeric micelles for drug delivery therapy [79, 80].
Caveolae are present on the plasma membrane as flask
shaped microdomains. They can assume complex
multi-lobed configurations with tubules linking these
assemblies to the cell membrane [81] or exist as vesi-
cles detached from the plasma membrane associated
in grape like clusters [82]. Caveolae are also dynamic
structures that have been shown to fuse with early
endosome and to form caveosome, late endosome and
multivesicular bodies [81]. Intense caveolae trafficking
occurs underneath the plasma membrane in rapid
“kiss and run” cycles in which the caveolar coat stays
intact and sequesters multivalent sphingolipids bound
cargos [83]. Caveolins, a family of hairpin-like palmi-
toylated integral membrane proteins that oligomerize
and bind to cholesterol and sphingolipids identify
caveolae. Cav1 and cav2 are ubiquitously expressed,
while cav3 expression is restricted to muscle cells.
Cav1 serves as a selective marker for caveolae. Cav1
has an unusual high affinity with cholesterol and re-
sists dissociation even with harsh detergents. Cav1
forms oligomeric complexes in the presence of choles-
terol contributing to caveolae genesis [82]. Metabolic
depletion of cholesterol or removal of cholesterol from
membrane disrupts caveolae [84], as does genetic abla-
tion of cav1 [81]. The unusual lipid composition of
caveolae confers buoyancy, resistance to solubilization
by non-ionic detergents such as Triton-X-100 at 4 °C.
This property together with the marker cav1 and the
distinctive buoyancy, form the basis for caveolae
characterization, identification and purification.
In this study the caveolae proteins cav1 and cav2 were
not depleted in the SL pericytes during the GTM challenge,
showing that GTM did not affect the structural integrity of
the caveolar microdomain. The complexity and the dyna-
mism of caveolae interactions in the cells physiology is
made evident by the thousands of proteins associated with
caveolae and is revealed by the mass spectrometry analysis.
The differences in the GO terms enriched in the specifically
expressed proteins in the GTM and control dataset show
the response of the cell in physiological and pathological
conditions. The subsequent analysis of proteins iso-
lated from caveolae with bioinformatics tools revealed
important patterns in the overrepresented cellular
components and processes.
The gene ontology enrichment analysis of the GTM data-
set shows that caveolae activity was significantly found in
the cytoplasm and in the cell membranes including vacu-
oles and vesicles, membrane protein complexes, exosome
and mitochondria. Within the “Biological process” ontology
the enriched GO categories showed significance for the
terms localization and transport which show that caveolae
actively participate in movement and transport of proteins,
lipids and small molecules in the processes and pathways
enriched in the analysis.
Transport and localization to membranes and cyto-
plasmic component has been described in literature and
are known interactions and activities established by
caveolae in the cell. Caveolae exist as individual micro-
domains clustering in stable multi-caveolar assemblies
or undergoing continuous cycling of fusion and internal-
ization while trafficking to and from the cell membrane,
intracellular vesicles and cytoplasm [83]. Interestingly,
overrepresented GO categories within the “cellular com-
ponent” ontology included “Extracellular exosome” and
“Mitochondrion”.
The activity of caveolae and cav1 in exosomes has
been only recently brought to attention. Exosomes
expressing CD63 and cav1 have been described in large
amount in plasma of melanoma patients [85]. Caveolae
have been shown to participate in uptake and internal-
ization, via endocytosis pathways, of exosomes released
from Epstein-Barr virus infected B cells by epithelial
cells [86]. Furthermore dynamin, a component of the
caveolae endocytic pathway, participates in the uptake of
exosomes containing anthrax toxin [87]. Exosomes are
potent mediators of intercellular communication; the
enrichment of the GO category “extracellular exosome”
suggests the existence of pathway(s) utilizing caveolae
transport for shuttling exosomes loaded with extracellular
material in and out of the cell in response to stress during
the GTM challenge. Particularly during pathological condi-
tions extracellular material and plasma membrane proteins
are delivered to lysosomes for degradation. Caveolae
and exosome cooperation may serve as a cellular
mechanism to enhance protein degradation or removal
of damaged cellular material, through their release to
cellular autophagocytic machinery or to the extracellu-
lar environment as exosomes. Immuno-staining and
transmission electron microscopy, have recently show
that caveolae and cav1 are expressed in mitochondria
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of rat pulmonary arterial smooth muscle cells [88],
and in mitochondria-associated membranes (MEMs)
in hepatocytes, connecting the endoplasmic reticulum
to mitochondria [89]. Cellular protection from damage
induced by a variety of insults has been suggested for
the transferring of cav1 between caveolae and mito-
chondria. Furthermore, it has been shown that the
caveolae-mitochondria interaction regulates the adap-
tation to cellular stress by modulating the structure
and function of mitochondria [19] and that cav1 is rele-
vant for mitochondrial functioning and lipids and meta-
bolic homeostasis [55]. GTM is known to induce cell
disruption and apoptosis in the inner ear increasing ROS,
inducing mitochondria oxidative damage and, conse-
quently, hearing loss. The enrichment of the GO category
“Mitochondrion”, and the association with caveolae, shows
an important synergy between mitochondria and caveolae
in GTM induced stress. This suggests the existence of
protective mechanisms in place for cell survival and for
mitochondria repair and adaptation to stress, in which ca-
veolae and caveolins play an important role as lipids and
molecule transporters to and from the mitochondria, in
order either to maintain the energy metabolism or to re-
spond to the increased energy demand of the cell.
The enrichments and the visualization analysis in control
and GTM uniquely segregating proteins showed dramatic
changes in quite different categories, giving for the first
time an insight to the complex proteomic alterations asso-
ciated with the administration of GTM to cells of the inner
ear. The bioinformatic data for the GTM proteome show
the cells in an active and stressed status where the signifi-
cant effort seems to reside in energy boosting, protein deg-
radation, biosynthesis, and vesicular transport. The increase
of cell metabolic activity, increased amino acid, fatty acid
and nucleotide biosynthesis, upregulated glycolysis, purine
metabolism, tricarboxylic acid (TCA) cycle, have been de-
scribed as a consequence of GTM in small colony variants
of Staphylococcus aureus [90]. Those same processes are
observed in our data (Fig. 5, Table 1A, and Additional file 4).
In particular, the TCA cycle is essential for a majority of
metabolic pathways and its serves as node connecting cata-
bolic energy gaining pathways with anabolic pathways. Its
upregulation provides more biosynthetic intermediates and
more redox potential in order to gain energy via oxidative
phosphorylation [90] Interestingly, the category oxidative
phosphorylation has been shown in our data only in
the proteome of GTM challenged cells (Fig. 5, and
Additional file 4), demonstrating the need for in-
creased energy possibly to counteract the damage of
the drug. The bioinformatic data for the control prote-
ome (Fig. 5, Additional file 4, Tables 3A, B and C and
Additional file 3) show that in the healthy cell the
caveolae participate in genetic information processing,
in transcription, in nucleotides binding and spliceosome
activity, in signal transduction, involving nucleus, ribo-
some, RNA transport, processing and binding, and DNA
maintenance. The enriched categories for the cellular
component ontology show that nucleic part and nucleus
are the most significant, suggesting a novel role for caveo-
lae in transferring and transport of genetic material. Our
findings support recent works that contribute to insights
for possible alternative of trafficking patterns involving ca-
veolae. Polyplexes formed by polymer-DNA complexes,
have been shown to reach the nucleus through a route in-
volving caveolae, in which the polyplexes accumulate into
Rab6- labelled Golgi and ER vesicles and ultimately are
transported into the nucleus, during ER mediated nuclear
envelope reassembly [91]. Moreover, it has been shown in
ovarian carcinoma cells that cav1 associates with the nu-
clear matrix and with inactive chromatin and colocalize
with nuclear inner membrane proteins and promoter se-
quences participating cell cycle progression, suggesting
that cav1 exerts a functional activity mediated by binding
to sequences of genes involved in proliferation [18]. The
difference in the proteomes of physiological and patho-
logical cell is an attractive target for developing therapies
for GTM and noise induced hearing loss. Changes in gene
products expression, have been reported in a study using
RNA sequencing to evaluate the response of inner ear hair
cells to GTM. The study showed that within 3 h of GTM
treatment, the mRNA level of more than three thousand
genes in the hair cells changed significantly [92]. More-
over, mice exposed to repeated acoustic blasts showed
injury to the auditory cortex and significant alterations
in the expression of multiple genes in the brain, known
to be involved in age- or noise-induced hearing impair-
ment [93].
The specifically expressed proteins dataset from GTM
treated cells showed that the highest enrichment signifi-
cance was reached in the GO category “Transferase
activity transferring phosphorus”. Proteins in this cat-
egory encompass all kinase activities participating in the
transfer of a phosphorous containing group from one
donor to an acceptor, thus activating pathways and cellu-
lar processes. The proteins listed in the category are
mostly protein kinases and in particular protein serine/
threonine kinases. Interestingly, the dynamic properties
of caveolae and their transport competence are regulated
by kinases. In particular, it has been shown that serine/
threonine kinases differentially regulate caveolae short
and long distance cycling between the cell surface and
intracellular organelles, and that caveolae move more
upon kinase activation [83]. A molecular switch triggered
by kinase activation suggests the increase of caveolae
dynamism in GTM treated cells. Caveolae increased trans-
port activity is confirmed in the data of the GOrilla
enrichment analysis and is visualized in the Proteomaps,
where “Transport” became the dominant subcategory in
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the top area “Cellular process”. A change of the cycling
mode from short to long range, and increased caveolae
transport activity and kinase activation are then plausible
consequences of GTM administration to the cells.
The identification of proteins uniquely segregating with
caveolae during the GTM challenge in the inner ear micro-
vasculature pericytes is formidable knowledge, since those
proteins are likely to be expressed predominantly or specific-
ally when the inner ear undergoes ototoxic or noise-induced
damage. These proteins are attractive targets, reachable with
therapeutic vectors through the bloodstream to the hardly
accessible inner ear.
The caveolae-mediated endocytosis process would offer
a significant advantage for delivering its load across the
cells efficiently, enhancing deep tissue and vascular pene-
tration of its cargo drugs. Activation of the caveolae endo-
cytic pathway has been shown in studies investigating the
internalization of co-polymers as potential drug delivery
vehicles [94].
Transport functions are controlled by Rab proteins,
which are key regulators of intracellular membrane traf-
ficking. Activated Rabs switch from a GDP form to a
GTP form. Interestingly, phosphate-transferring group
was a category enriched in the GTM uniquely expressed
proteins suggesting the activation of Rab pathways.
Remarkably, only Rab proteins in the GTM dataset and
not in control cells were significantly enriched, demon-
strating the relevance of the Rab-caveolae cooperation in
pathological condition. The increased segregation of Rab
proteins with caveolae in GTM treated cells and the
significant enrichment of the pool of Rab expressed in
the GTM treated vs untreated cells could be considered
as a marker of cellular stress for pathological condition
such as the GTM administration.
Once activated, Rabs are able to recruit (to different
membranes) different sets of downstream effectors re-
sponsible for all steps of vesicle trafficking [95] which
include regulation of vesicular movements, endocytosis,
movements of vesicles packaged with cargo proteins,
association with motor proteins that facilitate the move-
ment of vesicles along actin, microtubules, cytoskeleton
tethering factors that dock vesicles to target compart-
ments for membrane fusion. Each distinct membrane
compartment is targeted by a particular set of Rab
proteins. Evidence suggests that the Rabs and caveolae
share a common path in the cell transport processes.
Budded caveolae, can fuse with the early endosome in a
Rab5-dependent manner [20]. In HeLa cells, cholera
toxin and simian virus 40 (SV40) are transported to
endosomes by caveolar vesicles in a process dependent
on Rab5 [96]. The coordinated interactions of cav1 and
Rab11 regulate the apical recycling compartments in
polarized epithelial cells [21]. In glial cells the human
polyomavirus JC virus is sorted from early endosome to
a cav1 positive endosomal compartment in a Rab5
dependent step [97]. Overexpression of Rab7 and Rab9
in Niemann-Pick C fibrocytess mediate the Golgi
transport of caveolae-internalized glycosphingolipids
reducing intracellular accumulation of cholesterol and
increasing accumulation of neutral lipids [98]. The
specificity of Rab transport in hearing loss is slowly
gaining interest and is still rather scattered. In a study
assessing gene expression in guinea pig paraflocculus
structure in the cerebellum after acoustic trauma, the
protein Rab3A, which is involved in regulation of pre-
synaptic neurotransmitter release, showed no changes
[99]. A Mutation in the gene TBC1 Domain Family
Member 24 (TBC1D24), encoding for a GTPase acti-
vating the proteins Rab5 and Rab35, involved in endo-
some to lysosome trafficking as a mechanism for
degrading synaptic vesicles associated proteins, has
been shown to cause severe neurodegeneration and
deafness [100]. In HEK 293 cells otoferlin, a protein
involved in human autosomal recessive deafness, is
co-localized and co-expressed with Rab8 contributing
with trans-Golgi trafficking [41]. In a recently pub-
lished study, our group showed that a Single Nucleo-
tide Polymorphism (SNP) of the Rab11 effector
Rab11Fip1 is associated with a noise-induced hearing
loss [101]. In this study, cells incubated with GTM for
24 h at 1 mg/ml and 5 mg/ml significantly modified
the concentration of some of the Rab proteins tested.
The significant change in Rab8a, Rab9a, Rab13, Rab3gap2
shows the concentration effect of GTM on a family of
transport proteins, that interacts with multiple cell com-
partments and may influence more significant changes in
the cells. A concept recently emerging in Rab biology
suggests that compartment conversion in endosome matur-
ation is induced through a change in Rabs and their effector
molecules, that ultimately alters membrane function and
identity [102], and may affect the directional flow of cell
cargo transport in the cell.
Rab8a, Rab9a, Rab13, Rab3gap2 share activity in sev-
eral pathways. All four Rabs play a role in autophagy.
Rab 9a and Rab13 are active in vesicular protein trans-
port through the trans-Golgi network to endosomes.
Rab8a and Rab3gap2 share activities in extracellular ves-
icular transport. Rab8a and Rab13 play a role in cell-cell
junctions and in the transport of the glucose transporter
protein GLUT4, which regulates the glucose [103].
Autophagy is a protective process activated in the cells
to adapt to various stresses. The fact that four Rabs in a
pool of Rab proteins isolated with caveolae shared sig-
nificance in autophagy pathways is of particular interest.
Recent studies have shown the participation of cav1 in
autophagy process, in particular it has been shown that
phosphorylated cav1 functions to activate autophagy
under several stress conditions [104].
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Rab8a and Rab13 share trans-Golgi network vesicular
transport activity. The trans-Golgi network is a major
sorting, packing and delivering station of newly synthe-
sized proteins and lipids to their destinations [105] The
significant changes of Rab9a and Rab13 following the
GTM treatment may suggest impairment to lipids and
proteins transport, packing and sorting potentially con-
tributing to changes in the cells vesicular membranes
and transport pathways.
Extracellular cargo transport may be affected by the
GTM incubation. Rab8a and Rab3gap2 described respect-
ively in transcytosis and exocytosis significantly decreased
at the 5 mg/ml concentration. Transcytosis is one of the
potential roles described for caveolae. Numerous findings
propose that caveolae transcytose low density lipoporteins
(LDLs), albumin and insulin [106]. Rab8a has been associ-
ated with basolateral-to-apical transcytosis in polarized
Madin-Darby Canine Kidney Cells (MDCK) cells [107],
while Rab3gap2 had been shown to form with the protein
Rab3gap1 a complex acting in exocytosis and endocytosis,
and extracellular trafficking [108].
Two of the Rabs tested, Rab8a and Rab13, showed a
significant decrease after GTM incubation. Both Rabs
have been shown to play a role in cell-cell junctions.
Rab8a has been described in adherens junctions [109],
while Rab13 has been described in tight junctions [110].
Pericytes on the vessels of the SL strongly expressed gap
junction proteins [38], and tight junctions are present in
the cells of the lateral wall and BLB. [111]. Furthermore,
caveolae and cav1 have been associated with tight junc-
tion organization in the cerebral endothelium [112] and
have been shown to impact blood brain permeability in
ischemia reperfusion injury [113]. Finally, the insulin
regulated glucose transporter GLUT4 localizes to caveo-
lae after translocation to the plasma membrane [114].
Glucose deprivation in pheochromocytoma (PC)12 cells
translocates GLUT4 to the cell membrane, up-regulates
both cav-1 and GLUT4 and changes mitochondrial
membrane potential [115]. Taken together these findings
underline the importance of understanding the intracel-
lular trafficking machinery that associate Rabs and Cave-
olae for any manipulation of caveolae and their cargo in
the cytoplasm.
Conclusion
The results shown in the study demonstrate that GTM
exposure of SL pericytes induces changes in caveolae
proteome profile, specifically and significantly modifying
the expression of protein-encoding genes during the
challenge. Furthermore, the changes in protein expres-
sion impact the transport Rab GTPases, significantly
over representing pathways leading to the cell proteo-
lytic machinery, exocytosis, cytoplasm to membrane
transport and recycling and transport to and from the
Golgi apparatus. Finally, we describe for the first time
proteins associated with nonsyndromic deafness in SL
pericytes.
Our findings show that about 40% of the proteins seg-
regating with caveolae were uniquely found in the cells
challenged with GTM. These results are interesting in
view of the caveolae localization on the cell membrane,
its endocytic and transcytotic activity in the cell cyto-
plasm and the possibility of exploiting these features for
drug delivery to the hardly accessible cochlear inner ear.
Specifically expressed proteins could constitute a target
site for docking systemically administered blood-borne
vectors, carrying therapeutic agents, to be delivered to
the cochlear tissues. Insights and understanding of Rab
vesicular transport routes in the cell cytoplasm during
cochlear damage would allow the manipulation of caveo-
lae cytoplasmic path, to precisely and selectively direct
the caveolae and their cargoes.
Additional files
Additional file 1: Caveolin-1 Dot Blot analysis of gradient aliquots.
Caveolae-rich aliquots from CTRL and GTM treated cell lysates. Optiseal
gradients previously loaded with cell lysates were fractionated in 8 to 9
aliquots after the ultracentrifugation. Cav-1 signal was obtained with
Dot-Blot on PVDF membrane using 3 μl from each gradient aliquot using
anti-cav-1 antibody (Sigma-Aldrich, USA) with overnight incubation. The
aliquots with the strongest signal for cav-1 were selected for protein
separation and mass spectrometry analysis. The blots are representative
of three independent experiments. (PPTX 251 kb)
Additional file 2: Venn diagram from the three mass spectrometry
experiments. Only proteins detected at least in two of the three mass
spectrometry runs were used to build the diagram and further used in
the bioinformatics analysis. One thousand six hundred eighty two proteins
were found in the control set and 2379 proteins in the GTM set. Among
these, 948 proteins (40%) were uniquely segregating with caveolae in
GTM-treated cells; 251 proteins (15%) were uniquely segregating with
caveolae in the control dataset and 1431 proteins were commonly
expressed. (PPTX 106 kb)
Additional file 3: Table S3 A, B and C. Enrichment analysis of proteins
uniquely segregating with caveolae in untreated cells. The 251 proteins
uniquely segregating with caveolae in untreated cells where selected as the
target group for the GOrilla enrichment analysis. The control dataset plus
the GTM dataset were chosen as background group. The table shows the
complete list of significantly enriched GO terms to FDR q-value< 0.05. The
enrichment showed significance for terms in the categories “Biological
process”, “Cellular component” and “Molecular function”. The enriched terms
showed the suppressed activities and functions in the cells once GTM is
administered. (DOCX 34 kb)
Additional file 4: Proteomaps of the proteins uniquely segregating with
caveolae and untreated cells. Comparative visualization of the proteins
uniquely segregating with caveolae in control and GTM treated cells. The two
panels show the further division of the top area polygons (see Fig. 5) in sub-
categories for the control and the GTM dataset respectively. (TIFF 6509 kb)
Additional file 5: Rabs immunoblotting. SL pericytes were incubated
with increasing concentrations of GTM (1 mg/ml, 5 mg/ml,10 mg/ml
GTM) for 24 h. Immunoblots were obtained for each Rab protein from
the whole cell lysate. Protein quantification is expressed as the relative
quantity to the control for each Rab. Each graph is the result of n = 5
independent experiments for Rab3a, Rab4, Rab5, Rab22; n = 4 independent
experiments for Rab6b, Rab7, Rab23; n = 3 independent experiments for
Rab11 and Rab3b; n = 2 independent experiments for Rab6a. SEM was
Ghelfi et al. Proteome Science  (2018) 16:7 Page 23 of 26
calculated for each group. Although not significant, a trend can be drawn
from the analysis. Three Rab proteins Rab3a, Rab 6a, Rab7 showed a slight
increase at 5 mg/ml. Rab11 and 22a showed no change at any concentration
tested. In the Fig. A = Rab3a; B = Rab3b; C = Rab4; D = Rab 6a; E = Rab6b;
F = Rab5; G = Rab7; H = Rab11; I = Rab23 L = Rab22a. (PPTX 9718 kb)
Additional file 6: Rabs immunoblotting. SL pericytes were incubated with
increasing concentrations of GTM (1 mg/ml, 5 mg/ml,10 mg/ml GTM) for
24 h. Immunoblots were obtained for each Rab protein from the whole cell
lysate. Protein quantification is expressed as the relative quantity to the control
for each Rab. Each graph is the result of n = 5 independent experiments for
Rab3a, Rab4, Rab5, Rab22; n = 4 independent experiments for Rab6b, Rab7,
Rab23; n = 3 independent experiments for Rab11 and Rab3b; n = 2
independent experiments for Rab6a. SEM was calculated for each
group. Although not significant, a trend can be drawn from the analysis.
Three Rab proteins Rab3a, Rab 6a, Rab7 showed a slight increase at 5 mg/
ml. Rab11 and 22a showed no change at any concentration tested. In the
Fig. A = Rab3a; B = Rab3b; C = Rab4; D = Rab 6a; E = Rab6b; F = Rab5;
G = Rab7; H = Rab11; I = Rab23 L = Rab22a. (PPTX 7067 kb)
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